DE10351233A1 - Chemically stable oily emulsion herbicide concentrates, useful for selective weed control in crops, comprising sulfonamide herbicide, safener, organic solvent and sulfosuccinate - Google Patents

Abstract

New micro-emulsion concentrates (A) contain sulfonamide herbicide(s) (I) in suspended form, safener(s) (II), organic solvent(s) (III and sulfosuccinate(s) (IV). Independent claims are included for: (1) the production of (A); and (2) (A)-containing herbicidal compositions (B) (specifically suspensions, emulsion, suspo-emulsions or solutions). ACTIVITY : Herbicide; safener. MECHANISM OF ACTION : None given in the source material.

Description

The The present invention relates to the field of crop protection formulations. In particular, the invention relates to liquid formulations in the form of oil suspension concentrates, which herbicidal active compounds from the group of sulfonamides, in particular of phenylsulfonamides and heteroarylsulfonamides.

drugs for the Crop protection is generally not in its pure form used. Dependent on of the field of application and the type of application, as well as physical, chemical and biological parameters, the active ingredient is in mixture with usual Auxiliaries and additives used as an active ingredient formulation. Also the combinations with other agents to extend the spectrum of action and / or for the protection of crops (e.g., safeners, antidotes) are known.

formulations of active ingredients for Plant protection should generally be high in chemical and plant health physical stability, good applicability and user-friendliness and a broad have biological activity with high selectivity.

herbicides Active substances from the group of sulfonamides, such as sulfonylureas, generally have a high degree of chemical reactivity and are prone to chemical degradation, e.g. by hydrolysis.

One way to formulate chemically labile drugs is the preparation of solid formulations. Thus, formulations of active compounds from the group of sulfonylureas, in the form of powders, granules and tablets are known (eg in EP 764404 , WO 9834482, WO 9313658). However, the processes for the preparation of solid formulations, for example in the form of granules and tablets, are generally expensive, in particular when low-melting active substances or auxiliaries and additives are incorporated. In addition, solid formulations are generally more difficult to apply and less user friendly.

Liquid formulations of sulfonylureas are described, for example, in US 4599412 . US 4683000 . US 4671817 . EP 0245058 WO 01/82693 EP 0313317 . EP 0514768 . EP 0163598 and EP 0514769 ,

The Object of the present invention was to provide an improved To provide a crop protection formulation containing a high chemical stability as well as a high biological effectiveness and crop plant compatibility having.

These Task is solved through the special oil suspension concentrate of the present invention.

• a) ein oder mehrere herbizide Wirkstoffe aus der Gruppe der Sulfonamide, in suspendierter Form,
• b) ein oder mehrere Safener,
• c) ein oder mehrere organische Lösungsmittel, und
• d) ein oder mehrere Sulfosuccinate.

The present invention thus relates to an oil suspension concentrate containing

• a) one or more herbicidal active substances from the group of sulfonamides, in suspended form,
• b) one or more safeners,
• c) one or more organic solvents, and
• d) one or more sulfosuccinates.

• e) einen oder mehrere von a) und b) verschiedene agrochemische Wirkstoffe, und
• f) übliche Hilfs- und Zusatzstoffe.

In addition, the inventive oil suspension concentrate may optionally still contain as further components:

• e) one or more of a) and b) different agrochemical active substances, and
• f) customary auxiliaries and additives.

Under the term oil suspension concentrate (OD) becomes a suspension concentrate based on organic solvents Understood. In this case, one or more active ingredients in the organic Solvent suspended, other active ingredients can in the organic solvent solved be.

In the oil suspension concentrate according to the invention, the sulfonamide a) is present in suspended form in the organic solvent. This means that the majority (in wt .-%) of sulfonamide undissolved in finely divided form, a minor part of the sulfonamide may be present dissolved. Preferably, the sulfonamide in the organic solvent to more than 80 wt .-%, more preferably suspended to more than 90 wt .-%, each based on the total amount of sulfonamide in the oil of the invention suspension concentrate.

Preferred sulfonamides a) are phenylsulfonamides and heteroarylsulfonamides and other sulfonamides, such as amidosulfuron. Examples of suitable phenylsulfonamides a) are compounds from the group of the phenylsulfonylaminocarbonyltriazolinones or the phenylsulfonylureas, preferably from the group of the phenylsulfonylureas. The term phenylsulfonylureas also includes those sulfonylureas in which the phenyl group is bonded to the sulfone group (SO ₂ ) via a spacer such as CH ₂ , O or NH. Examples of phenylsulfonylaminocarbonyltriazolinones are flucarbazones or propoxycarbazones and / or salts thereof. The sulfonamides a) are commercially available and / or can be prepared by known processes as described, for example, in EP-A-7687, EP-A-30138, US 5,057,144 and US 5,534,486 ,

Suitable phenylsulfonamides are, for example, phenylsulfonamides of the general formula (I) and / or salts thereof, R ^α - (A) _m -SO ₂ -NR ^β -CO- (NR ^γ) _n -R ^δ (I) wherein
R ^{α is} a phenyl radical which is unsubstituted or substituted, and where the phenyl radical, including substituents, has 1-30 C atoms, preferably 1-20 C atoms,
R ^{β is} a hydrogen atom or a hydrocarbon radical which is unsubstituted or substituted and contains, including substituents, 1-10 C atoms, for example unsubstituted or substituted C ₁ -C ₆ -alkyl, preferably a hydrogen atom or methyl,
R ^{γ is} a hydrogen atom or a hydrocarbon radical which is unsubstituted or substituted and, including substituents, has 1-10 C atoms, for example unsubstituted or substituted C ₁ -C ₆ -alkyl, preferably a hydrogen atom or methyl,
A is CH ₂ , O or NH, preferably O,
m is equal to zero or 1,
n is equal to zero or 1, preferably equal to 1, and
R ^{δ is} a heterocyclic radical such as a pyridyl radical, a triazinyl radical or a triazolinone radical.

Preferred phenylsulfonamides are phenylsulfonylureas, for example phenylsulfonylureas of the general formula (II) and / or salts thereof, R ^α - (A) _m -SO ₂ -NR ^β -CO-NR ^γ -R ^δ (II) wherein
R ^{α is} a phenyl radical which is unsubstituted or substituted, and where the phenyl radical, including substituents, has 1-30 C atoms, preferably 1-20 C atoms,
R ^{β is} a hydrogen atom or a hydrocarbon radical which is unsubstituted or substituted and contains, including substituents, 1-10 C atoms, for example unsubstituted or substituted C ₁ -C ₆ -alkyl, preferably a hydrogen atom or methyl,
R ^{γ is} a hydrogen atom or a hydrocarbon radical which is unsubstituted or substituted and, including substituents, has 1-10 C atoms, for example unsubstituted or substituted C ₁ -C ₆ -alkyl, preferably a hydrogen atom or methyl,
A is CH ₂ , O or NH, preferably O,
m is equal to zero or 1, and
R ^{δ is} a heterocyclic radical such as a pyridyl radical or a triazinyl radical.

worin
R⁴ C₁-C₄-Alkoxy, vorzugsweise C₂-C₄-Alkoxy, oder CO-R^a ist, worin R^a gleich OH, C₁-C₄-Alkoxy oder NR^bR^c ist, worin R^b und R^c unabhängig voneinander gleich oder verschieden H oder C₁-C₄-Alkyl sind,
R⁵ Halogen, vorzugsweise Iod, oder (A)_n-NR^dR^e ist, worin n gleich Null oder 1 ist,
A eine Gruppe CR'R'' ist, worin R' und R'' unabhängig voneinander gleich oder verschieden H oder C₁-C₄-Alkyl sind, R^d gleich H oder C₁-C₄-Alkyl ist und R^e ein Acylrest wie Formyl oder C₁-C₄-Alkyl-Sulfonyl ist, und R⁵ für den Fall, daß R⁴ gleich C₁-C₄-Alkoxy, vorzugsweise C₂-C₄-Alkoxy, bedeutet auch H sein kann,
R⁶ H oder C₁-C₄-Alkyl ist,
m gleich Null oder 1 ist,
X und Y unabhängig voneinander gleich oder verschieden Halogen oder NR'R'', worin R' und R'' gleich oder verschieden H oder C₁-C₄-Alkyl sind, oder C₁-C₆-Alkyl, C₁-C₆-Alkoxy, C₁-C₆-Alkylthio, C₃-C₆-Cycloalkyl, C₂-C₆-Alkenyl, C₂-C₆-Alkynyl, C₃-C₆-Alkenyloxy oder C₃-C₆-Alkynyloxy sind, wobei jeder der acht letztgenannten Reste unsubstituiert oder durch einen oder mehrere Reste aus der Gruppe Halogen, C₁-C₄-Alkoxy und C₁-C₄-Alkylthio substituiert ist, vorzugsweise C₁-C₄-Alkyl oder C₁-C₄-Alkoxy, und
Z gleich CH oder N ist.Preference is given to phenylsulfonylureas of the formula (III) and / or salts thereof,

wherein
R ^{4 is} C ₁ -C ₄ -alkoxy, preferably C ₂ -C ₄ -alkoxy, or CO-R ^a , where R ^a is OH, C ₁ -C ₄ -alkoxy or NR ^b R ^c , where R ^b and R ^c, independently of one another or identical, are H or C ₁ -C ₄ -alkyl,
R ^{5 is} halogen, preferably iodine, or (A) _n -NR ^d R ^e , where n is equal to zero or 1,
A is a group CR'R "in which R 'and R" are each, identically or differently, H or C ₁ -C ₄ alkyl, R ^d is H or C ₁ -C ₄ alkyl and R ^e is Acyl radical such as formyl or C ₁ -C ₄ -alkyl-sulfonyl, and R ⁵ in the case where R ⁴ is C ₁ -C ₄ -alkoxy, preferably C ₂ -C ₄ -alkoxy, may also be H,
R ^{6 is} H or C ₁ -C ₄ -alkyl,
m is zero or 1,
X and Y independently of one another are identical or different halogen or NR'R ", in which R 'and R" are, identically or differently, H or C ₁ -C ₄ -alkyl, or C ₁ -C ₆ -alkyl, C ₁ -C _6- alkoxy, C ₁ -C ₆ -alkylthio, C ₃ -C ₆ -cycloalkyl, C ₂ -C ₆ -alkenyl, C ₂ -C ₆ -alkynyl, C ₃ -C ₆ -alkenyloxy or C ₃ -C ₆ - Alkynyloxy, each of the eight latter radicals is unsubstituted or substituted by one or more radicals from the group consisting of halogen, C ₁ -C ₄ alkoxy and C ₁ -C ₄ alkylthio, preferably C ₁ -C ₄ alkyl or C ₁ -C ₄ alkoxy, and
Z is CH or N.

• a) R⁴ gleich CO-(C₁-C₄-Alkoxy) ist, R⁵ gleich Halogen, vorzugsweise Jod ist, oder R⁵ gleich CH₂-NHR^e ist, worin R^e ein Acylrest, vorzugsweise C₁-C₄-Alkyl-Sulfonyl ist, und m gleich Null ist,
• b) R⁴ gleich CO-N(C₁-C₄-Alkyl)₂, R⁵ gleich NHR^e ist, worin R^e ein Acylrest, vorzugsweise Formyl ist, und m gleich Null ist, oder
• c) R⁴ gleich C₂-C₄-Alkoxy, R⁵ gleich H und m gleich 1 ist.

Particular preference is given to phenylsulfonylureas of the general formula (III) and / or their salts, in which

• a) R ⁴ is CO- (C ₁ -C ₄ -alkoxy), R ⁵ is halogen, preferably iodine, or R ⁵ is CH ₂ -NHR ^e , where R ^{e is} an acyl radical, preferably C ₁ -C ₄ Alkyl sulfonyl, and m is zero,
• b) R ⁴ is CO-N (C ₁ -C ₄ alkyl) ₂ , R ⁵ is NHR ^e , where R ^{e is} an acyl radical, preferably formyl, and m is zero, or
• c) R ⁴ is C ₂ -C ₄ alkoxy, R ⁵ is H and m is 1.

typical Phenylsulfonylureas include the compounds listed below and their salts, such as the sodium salts: bensulfuron-methyl, chlorimuron-ethyl, Chlorosulfuron, cinosulfuron, cyclosulfamuron, ethametsulfuronmethyl, Ethoxysulfuron and its sodium salt, metsulfuron-methyl, oxasulfuron, Primisulfuron-methyl, prosulfuron, sulfometuron-methyl, triasulfuron, Tribenuronmethyl, triflusulfuron-methyl, tritosulfuron, iodosulfuron-methyl and its sodium salt (WO 92/13845), mesosulfuron-methyl and its Sodium salt (Agrow No. 347, March 3 2000, page 22 (PJB Publications Ltd. 2000)) and foramsulfuron and its sodium salt (Agrow No. 338, October 15, 1999, page 26 (PJB Publications Ltd. 1999)).

Especially preferred phenylsulfonamides are: iodosulfuron-methyl (A1.1) and its sodium salt (A1.2), mesosulfuron-methyl (A2.1) and its Sodium salt (A2.2), foramsulfuron (A3.1) and its sodium salt (A3.2), flucarbazone (A4.1) and its sodium salt (A4.2), propoxycarbazone (A5.1) and its sodium salt (A5.2) and ethoxysulfuron (A6.1) and its sodium salt (A6.2), metsulfuron methyl (A7.1) and its sodium salt (A7.2), tribenuron-methyl (A8.1) and its sodium salt (A8.2), Chlorosulfuron (A9.1) and its sodium salt (A9.2).

The listed above Drugs are e.g. known from "The Pesticide Manual", 12th edition (2000), The British Crop Protection Council or the individual Active ingredients listed References.

Suitable heteroarylsulfonamides a) include, for example, compounds from the group of heteroarylsulfonylaminocarbonyltriazolinones or heteroarylsulfonylureas, preferably from the group of heteroarylsulfonylureas. The term heteroarylsulfonylureas also includes those sulfonylureas in which the heteroaryl group is bonded to the sulfone group (SO ₂ ) via a spacer, such as CH ₂ , O or NH.

Suitable heteroarylsulfonamides are, for example, sulfonamides of the general formula (IV) and / or their salts, R ^{α '} - (A') _{m '} -SO ₂ -NR ^β' - CO- (NR ^{γ '} ) _n ^' - R ^{δ '} (IV) wherein
R ^{α 'is} a heteroaryl group which is unsubstituted or substituted and wherein the heteroaryl group including substituents has 1-30 C atoms, preferably 1-20 C atoms, R ^{β' is} a hydrogen atom or a hydrocarbon group which is unsubstituted or substituted and including 1-10 C atoms, for example unsubstituted or substituted C ₁ -C ₆ -alkyl, preferably a hydrogen atom or methyl,
R ^{γ 'is} a hydrogen atom or a hydrocarbon radical which is unsubstituted or substituted and contains 1-10 C atoms inclusive of substituents, for example unsubstituted or substituted C ₁ -C ₆ -alkyl, preferably a hydrogen atom or methyl,
A 'is CH ₂ , O or NH, preferably O,
m 'is equal to zero or 1,
n 'is equal to zero or 1, preferably equal to 1, and
R ^{δ 'is} a heterocyclic radical such as a pyridyl radical, a triazinyl radical or a triazolinone radical.

Preferred heteroarylsulfonamides are heteroarylsulfonylureas, for example sulfonylureas of the general formula (V) and / or salts thereof, R ^{α '} - (A') _{m '} -SO ₂ -NR ^β' -CO-NR ^{γ '} -R ^δ' (V) wherein
R ^{α 'is} a heteroaryl radical which is unsubstituted or substituted, and where the heteroaryl radical including substituents has 1-30 C atoms, preferably 1-20 C atoms,
R ^{β 'is} a hydrogen atom or a hydrocarbon radical which is unsubstituted or substituted and, including substituents, has 1-10 C atoms, for example unsubstituted or substituted C ₁ -C ₆ -alkyl, preferably a hydrogen atom or methyl,
R ^{γ 'is} a hydrogen atom or a hydrocarbon radical which is unsubstituted or substituted and contains 1-10 C atoms inclusive of substituents, for example unsubstituted or substituted C ₁ -C ₆ -alkyl, preferably a hydrogen atom or methyl,
A 'is CH ₂ , O or NH, preferably 0,
m 'is equal to zero or 1, and
R ^{δ 'is} a heterocyclic radical such as a pyridyl radical or a triazinyl radical.

und für n' gleich Null, R^δ' ein Triazolinonrest ist, vorzugsweise

R⁷ (C₁-C₁₀)Alkyl, welches optional substituiert ist mit Halogen (F, Cl, Br, I) oder (C₁-C₃)Halo-Alkyl,
R⁸ (C₁-C₁₀)Alkyl, welches optional substituiert ist mit Halogen (F, Cl, Br, I) oder (C₁-C₃)Halo-Alkyl,
X und Y unabhängig voneinander gleich oder verschieden Halogen oder NR'R'', worin R' und R'' gleich oder verschieden H oder C₁-C₄-Alkyl sind, oder C₁-C₆-Alkyl, C₁-C₆-Alkoxy, C₁-C₆-Alkylthio, C₃-C₆-Cycloalkyl, C₂-C₆-Alkenyl, C₂-C₆-Alkynyl, C₃-C₆-Alkenyloxy oder C₃-C₆-Alkynyloxy sind, wobei jeder der acht letztgenannten Reste unsubstituiert oder durch einen oder mehrere Reste aus der Gruppe Halogen, C₁-C₄-Alkoxy und C₁-C₄-Alkylthio substituiert ist, vorzugsweise C₁-C₄-Alkyl oder C₁-C₄-Alkoxy.Particularly preferred are heteroarylsulfonamides of the following formula (VI), R ^{α '} -SO ₂ -NH-CO- (NR ^{γ ')} _{n '} -R ^δ' (VI) in which
R ^{α 'is} a substituted heteroaryl radical, such as substituted pyridyl, thienyl, pyrazolyl or imidazolyl,
R ^{γ 'is} H, (C ₁ -C ₃ ) alkyl, optionally substituted by halogen (F, C, Br, I) or (halo) alkoxy (C ₁ -C ₃ ), preferably H or methyl,
for n 'is equal to 1, R ^{δ' is} a pyridyl radical or a triazinyl radical, preferably

and for n 'equal to zero, R ^{δ' is} a triazolinone radical, preferably

R ^{7 is} (C ₁ -C ₁₀ ) alkyl which is optionally substituted by halogen (F, Cl, Br, I) or (C ₁ -C ₃ ) haloalkyl,
R ^{8 is} (C ₁ -C ₁₀ ) alkyl which is optionally substituted by halogen (F, Cl, Br, I) or (C ₁ -C ₃ ) haloalkyl,
X and Y independently of one another are identical or different halogen or NR'R ", in which R 'and R" are, identically or differently, H or C ₁ -C ₄ -alkyl, or C ₁ -C ₆ -alkyl, C ₁ -C _6- alkoxy, C ₁ -C ₆ -alkylthio, C ₃ -C ₆ -cycloalkyl, C ₂ -C ₆ -alkenyl, C ₂ -C ₆ -alkynyl, C ₃ -C ₆ -alkenyloxy or C ₃ -C ₆ - Alkynyloxy, each of the eight latter radicals is unsubstituted or substituted by one or more radicals from the group consisting of halogen, C ₁ -C ₄ alkoxy and C ₁ -C ₄ alkylthio, preferably C ₁ -C ₄ alkyl or C ₁ -C ₄ alkoxy.

, worin
R⁹ (C₁-C₆)Alkyl, (C₁-C₆)Alkoxy, (C₂-C₆)Alkenyloxy, (C₂-C₆)Alkinyloxy, (C₁-C₆)Alkylsulfonyl, (C₁-C₆)Alkylcarbonyl, (C₁-C₆)Alkoxycarbonyl, (C₂-C₆)Alkenyloxycarbonyl, (C₂-C₆)Alkinyloxycarbonyl, CONR'R'', (C₁-C₆)Halo-Alkyl, (C₁-C₆)Halo-Alkoxy, (C₂-C₆)Halo-Alkenyloxy, (C₂-C₆)Halo-Alkinyloxy, (C₁-C₆)Halo-Alkylsulfonyl, (C₁-C₆)Halo-Alkylcarbonyl, (C₁-C₆)Halo-Alkoxycarbonyl, (C₂-C₆)Halo-Alkenyloxycarbonyl, (C₂-C₆)Halo-Alkinyloxycarbonyl,
R¹⁰ H, (C₁-C₃)Alkyl, (C₁-C₃)Alkoxy, (C₁-C₃)Halo-Alkyl, (C₁-C₃)Halo-Alkoxy oder Halogen (F, Cl, Br, I),
I Null oder 1,
R¹¹ (C₁-C₆)Alkyl, (C₁-C₆)Alkoxy, (C₂-C₆)Alkenyloxy, (C₂-C₆)Alkinyloxy, (C₁-C₆)Alkylsulfonyl, (C₁-C₆)Alkylcarbonyl, (C₁-C₆)Alkoxycarbonyl, (C₂-C₆)Alkenyloxycarbonyl, (C₂-C₆)Alkinyloxycarbonyl, (C₁-C₆)Halo-Alkyl, (C₁-C₆)Halo-Alkoxy, (C₂-C₆)Halo-Alkenyloxy, (C₂-C₆)Halo-Alkinyloxy, (C₁-C₆)Halo-Alkylsulfonyl, (C₁-C₆)Halo-Alkylcarbonyl, (C₁-C₆)Halo-Alkoxycarbonyl, (C₂-C₆)Halo-Alkenyloxycarbonyl, (C₂-C₆)Halo-Alkinyloxycarbonyl, CONR'R'',
R¹² Halogen (F, Cl, Br, I), (C₁-C₆)Alkyl, (C₁-C₆)Alkoxy, (C₁-C₆)Alkylsulfonyl, (C₁-C₆)Alkoxycarbonyl, (C₂-C₆)Alkenyloxycarbonyl, (C₂-C₆)Alkinyloxycarbonyl, (C₁-C₆)Halo-Alkyl, (C₁-C₆)Halo-Alkoxy, (C₁-C₆)Halo-Alkylsulfonyl, (C₁-C₆)Halo-Alkoxycarbonyl, (C₂-C₆)Halo-Alkenyloxycarbonyl, (C₂-C₆)Halo-Alkinyloxycarbonyl,
R¹³ (C₁-C₆)Alkoxycarbonyl, (C₂-C₆)Alkenyloxycarbonyl, (C₂-C₆)Alkinyloxycarbonyl, (C₁-C₆)Alkyl, (C₁-C₆)Alkoxy, (C₁-C₆)Alkylsulfonyl, (C₁-C₆)Halo-Alkoxycarbonyl, (C₂-C₆)Halo-Alkenyloxycarbonyl, (C₂-C₆)Halo-Alkinyloxycarbonyl, (C₁-C₆)Halo-Alkyl, (C₁-C₆)Halo-Alkoxy, (C₁-C₆)Halo-Alkylsulfonyl, Halogen (F, Cl, Br, I), CONR'R'', oder R¹³ ist ein heterocylischer Ring der gesättigt, ungesättigt oder aromatisch sein kann und vorzugsweise 4-6-Ringatome und eines oder mehrere Heteroatome aus der Gruppe N, O, S enthält, und optional durch einen oder mehrere Substituenten, vorzugsweise aus der Gruppe (C₁-C₃)Alkyl, (C₁-C₃)Alkoxy, (C₁-C₃)Halo-Alkyl, (C₁-C₃)Halo-Alkoxy oder Halogen substituiert sein kann, besonders bevorzugt

R¹⁴ H, Halogen (F, C, Br, I), (C₁-C₆)Alkyl, (C₁-C₆)Halo-Alkyl,
R¹⁵ H, (C₁-C₆)Alkyl, (C₁-C₆)Halo-Alkyl,
R¹⁶ (C₁-C₆)Alkyl, (C₁-C₆)Alkoxy, (C₂-C₆)Alkenyloxy, (C₂-C₆)Alkinyloxy, (C₁-C₆)Alkylsulfonyl, (C₁-C₆)Alkylcarbonyl, (C₁-C₆)Alkoxycarbonyl, (C₂-C₆)Alkenyloxycarbonyl, (C₂-C₆)Alkinyloxycarbonyl, (C₁-C₆)Halo-Alkyl, (C₁-C₆)Halo-Alkoxy, (C₂-C₆)Halo-Alkenyloxy, (C₂-C₆)Halo-Alkinyloxy, (C₁-C₆)Halo-Alkylsulfonyl, (C₁-C₆)Halo-Alkylcarbonyl, (C₁-C₆)Halo-Alkoxycarbonyl, (C₂-C₆)Halo-Alkenyloxycarbonyl, (C₂-C₆)Halo-Alkinyloxycarbonyl, CONR'R'', insbesondere SO₂Ethyl, und
R' und R'' unabhängig voneinander H, (C₁-C₆)Alkyl, (C₁-C₆)Haloalkyl, (C₂-C₆)Alkenyl, (C₂-C₆)Haloalkenyl, (C₂-C₆)Alkinyl, (C₂-C₆)Haloalkinyl sind, oder NR'R'' bildet einen heterocylischen Ring der gesättigt, ungesättigt oder aromatisch sein kann und vorzugsweise 4-6-Ringatome und eines oder mehrere Heteroatome aus der Gruppe N, O, S enthält, und optional durch einen oder mehrere Substituenten, vorzugsweise aus der Gruppe (C₁-C₃)Alkyl, (C₁-C₃)Alkoxy, (C₁-C₃)Halo-Alkyl, (C₁-C₃)Halo-Alkoxy oder Halogen substituiert sein kann.More preferably, R ^{α 'is the} same

in which
R ^{9 is} (C ₁ -C ₆ ) alkyl, (C ₁ -C ₆ ) alkoxy, (C ₂ -C ₆ ) alkenyloxy, (C ₂ -C ₆ ) alkynyloxy, (C ₁ -C ₆ ) alkylsulfonyl, (C ₁ -C ₆ ) alkylcarbonyl, (C ₁ -C ₆ ) alkoxycarbonyl, (C ₂ -C ₆ ) alkenyloxycarbonyl, (C ₂ -C ₆ ) alkynyloxycarbonyl, CONR'R '', (C ₁ -C ₆ ) haloalkyl, (C ₁ -C ₆ ) halo-alkoxy, (C ₂ -C ₆ ) halo-alkenyloxy, (C ₂ -C ₆ ) halo -alkynyloxy, (C ₁ -C ₆ ) haloalkylsulfonyl, (C ₁ -C ₆ ) Haloalkylcarbonyl, (C ₁ -C ₆ ) haloalkoxycarbonyl, (C ₂ -C ₆ ) halo-alkenyloxycarbonyl, (C ₂ -C ₆ ) haloalkynyloxycarbonyl,
R ¹⁰ is H, (C ₁ -C ₃₎ alkyl, (C ₁ -C ₃₎ alkoxy, (C ₁ -C ₃₎ alkyl-halo, (C ₁ -C ₃₎ halo-alkoxy or halogen (F, Cl, Br, I),
I zero or 1,
R ^{11 is} (C ₁ -C ₆ ) alkyl, (C ₁ -C ₆ ) alkoxy, (C ₂ -C ₆ ) alkenyloxy, (C ₂ -C ₆ ) alkynyloxy, (C ₁ -C ₆ ) alkylsulfonyl, (C ₁ -C ₆ ) alkylcarbonyl, (C ₁ -C ₆ ) alkoxycarbonyl, (C ₂ -C ₆ ) alkenyloxycarbonyl, (C ₂ -C ₆ ) alkynyloxycarbonyl, (C ₁ -C ₆ ) haloalkyl, (C ₁ -C ₆ ) Halo-alkoxy, (C ₂ -C ₆ ) halo-alkenyloxy, (C ₂ -C ₆ ) halo -alkynyloxy, (C ₁ -C ₆ ) halo-alkylsulfonyl, (C ₁ -C ₆ ) -haloalkylcarbonyl, ( C ₁ -C ₆ ) haloalkoxycarbonyl, (C ₂ -C ₆ ) halo-alkenyloxycarbonyl, (C ₂ -C ₆ ) haloalkynyloxycarbonyl, CONR'R '',
R ^{12 is} halogen (F, Cl, Br, I), (C ₁ -C ₆ ) alkyl, (C ₁ -C ₆ ) alkoxy, (C ₁ -C ₆ ) alkylsulfonyl, (C ₁ -C ₆ ) alkoxycarbonyl, ( C ₂ -C ₆₎ alkenyloxycarbonyl, (C ₂ -C ₆₎ alkynyloxycarbonyl, (C ₁ -C ₆₎ alkyl-halo, (C ₁ -C ₆₎ alkoxy halo, (C ₁ -C ₆₎ halo alkylsulfonyl, (C ₁ -C ₆ ) haloalkoxycarbonyl, (C ₂ -C ₆ ) halo-alkenyloxycarbonyl, (C ₂ -C ₆ ) haloalkynyloxycarbonyl,
R ^{13 is} (C ₁ -C ₆ ) alkoxycarbonyl, (C ₂ -C ₆ ) alkenyloxycarbonyl, (C ₂ -C ₆ ) alkynyloxycarbonyl, (C ₁ -C ₆ ) alkyl, (C ₁ -C ₆ ) alkoxy, (C ₁ -C ₆ ) alkylsulfonyl, (C ₁ -C ₆ ) haloalkoxycarbonyl, (C ₂ -C ₆ ) halo-alkenyloxycarbonyl, (C ₂ -C ₆ ) haloalkynyloxycarbonyl, (C ₁ -C ₆ ) haloalkyl, (C ₁ -C ₆ ) haloalkoxy, (C ₁ -C ₆ ) haloalkylsulfonyl, halogen (F, Cl, Br, I), CONR'R '', or R ¹³ is a heterocyclic ring which is saturated, unsaturated or is aromatic and preferably contains 4-6 ring atoms and one or more heteroatoms from the group N, O, S, and optionally by one or more substituents, preferably from the group (C ₁ -C ₃ ) alkyl, (C ₁ -C ₃₎ alkoxy, (C ₁ -C ₃₎ alkyl-halo, (C ₁ -C ₃₎ halo-alkoxy or halogen may be substituted, more preferably

R ¹⁴ H, halogen (F, C, Br, I), (C ₁ -C ₆ ) alkyl, (C ₁ -C ₆ ) haloalkyl,
R ^{15 is} H, (C ₁ -C ₆ ) alkyl, (C ₁ -C ₆ ) haloalkyl,
R ^{16 is} (C ₁ -C ₆ ) alkyl, (C ₁ -C ₆ ) alkoxy, (C ₂ -C ₆ ) alkenyloxy, (C ₂ -C ₆ ) alkynyloxy, (C ₁ -C ₆ ) alkylsulfonyl, (C ₁ -C ₆ ) alkylcarbonyl, (C ₁ -C ₆ ) alkoxycarbonyl, (C ₂ -C ₆ ) alkenyloxycarbonyl, (C ₂ -C ₆ ) alkynyloxycarbonyl, (C ₁ -C ₆ ) haloalkyl, (C ₁ -C ₆ ) Halo-alkoxy, (C ₂ -C ₆ ) halo-alkenyloxy, (C ₂ -C ₆ ) halo -alkynyloxy, (C ₁ -C ₆ ) halo-alkylsulfonyl, (C ₁ -C ₆ ) -haloalkylcarbonyl, ( C ₁ -C ₆ ) haloalkoxycarbonyl, (C ₂ -C ₆ ) halo-alkenyloxycarbonyl, (C ₂ -C ₆ ) haloalkynyloxycarbonyl, CONR'R ", especially SO ₂ ethyl, and
R 'and R "are each independently H, (C ₁ -C ₆ ) alkyl, (C ₁ -C ₆ ) haloalkyl, (C ₂ -C ₆ ) alkenyl, (C ₂ -C ₆ ) haloalkenyl, (C ₂ - C ₆ ) alkynyl, (C ₂ -C ₆ ) haloalkynyl, or NR'R '' forms a heterocyclic ring which may be saturated, unsaturated or aromatic and preferably 4-6 ring atoms and one or more heteroatoms from the group N, O, S, and optionally by one or more substituents, preferably from the group (C ₁ -C ₃ ) alkyl, (C ₁ -C ₃ ) alkoxy, (C ₁ -C ₃ ) haloalkyl, (C ₁ - C ₃ ) halo-alkoxy or halogen may be substituted.

Particularly preferred heteroarylsulfonylureas are, for example, nicosulfuron (A10.1) and its salts, such as the sodium salt (A10.2), rimsulfuron (A11.1) and its salts, such as the sodium salt (A11.2), thifensulfuron-methyl (A12.1) and its salts such as the sodium salt (A12.2), pyrazosulfuron-ethyl (A13.1) and its salts, such as the sodium salt (A13.2), flupyrsulfuron-methyl (A14.1) and its salts, such as the sodium salt (A14.2), sulfosulfuron (A15.1) and its salts, such as the sodium salt (A15.2), trifloxysulfuron (A16.1) and its salts, such as the sodium salt (A16.2), azimsulfuron (A17.1) and its salts Salts such as the sodium salt (A17.2), flazasulfuron (A18.1) and its salts such as the sodium salt (A18.2) and flucetosulfuron (1- [3 - [[[[(4,6-dimethoxy-2-pyrimidinyl) amino] carbonyl] amino] sulfonyl] -2-pyridinyl] -2-fluoropropyl methoxyacetate, (A19.1)) and its salts, such as the sodium salt (A 19.2).

The listed above Drugs are e.g. known from "The Pesticide Manual", 12th edition (2000), The British Crop Protection Council or the individual Active ingredients listed References.

For the purposes of the present invention, the term sulfonamides a) contained as component in the oil suspension concentrates according to the invention always includes all forms of use such as acids, esters, salts and isomers, such as stereoisomers and optical isomers. Thus, besides the neutral compounds, their salts with inorganic and / or organic counterions are always to be understood. For example, sulfonamides can form salts in which the hydrogen of the -SO ₂ -NH group is replaced by a cation suitable for agriculture. These salts are, for example, metal salts, in particular alkali metal salts or alkaline earth metal salts, in particular sodium and potassium salts, or else ammonium salts or salts with organic amines. Likewise, salt formation can take place by addition of an acid to basic groups, such as, for example, amino and alkylamino. Suitable acids for this purpose are strong inorganic and organic acids, for example HCl, HBr, H ₂ SO ₄ or HNO ₃ . Preferred esters are the alkyl esters, in particular the C ₁ -C ₁₀ -alkyl esters such as methyl esters.

So far in this specification the term acyl radical is used this the remainder of an organic acid, formally by cleavage an OH group is formed from the organic acid, e.g. the rest a carboxylic acid and residues thereof derived acids like the thiocarboxylic acid, optionally N-substituted iminocarboxylic acids or the residues of carbonic acid monoesters, optionally N-substituted carbamic acids, sulfonic acids, sulfinic acids, phosphonic acids, phosphinic acids.

An acyl radical is preferably formyl or acyl from the group CO-R ^z , CS-R ^z , CO-OR ^z , CS-OR ^z , CS-SR ^z , SOR ^z or SO ₂ R ^z , where R ^{z are} each a C ₁ -C ₁₀ -hydrocarbon radical such as C ₁ -C ₁₀ -alkyl or C ₆ -C ₁₀ -aryl which is unsubstituted or substituted, for example by one or more substituents from the group halogen such as F, Cl, Br, I, alkoxy, Haloalkoxy, hydroxy, amino, nitro, cyano or alkylthio, or R ^z denotes aminocarbonyl or aminosulfonyl, where the latter two radicals are unsubstituted, N-monosubstituted or N, N-disubstituted, for example by substituents selected from the group alkyl or aryl.

Acyl is, for example, formyl, haloalkylcarbonyl, alkylcarbonyl, such as (C ₁ -C ₄ ) alkylcarbonyl, phenylcarbonyl, where the phenyl ring may be substituted, or alkyloxycarbonyl, such as (C ₁ -C ₄ ) alkyloxycarbonyl, phenyloxycarbonyl, benzyloxycarbonyl, alkylsulfonyl, such as (C ₁ -C ₄ ) alkylsulfonyl, alkylsulfinyl, such as C ₁ -C ₄ (alkylsulfinyl), N-alkyl-1-iminoalkyl, such as N- (C ₁ -C ₄ ) -1-imino (C ₁ -C ₄ ) alkyl and other residues of organic acids.

One Hydrocarbon radical means a straight-chain, branched or cyclic and saturated or unsaturated aliphatic or aromatic hydrocarbon radical, e.g. alkyl, Alkenyl, alkynyl, cycloalkyl, cycloalkenyl or aryl. A hydrocarbon radical preferably has 1 to 40 C atoms, preferably 1 to 30 C atoms on; particularly preferably a hydrocarbon radical alkyl, Alkenyl or alkynyl with up to 12 C atoms or cycloalkyl with 3, 4, 5, 6 or 7 ring atoms or phenyl.

aryl means a mono-, bi- or polycyclic aromatic system, for example, phenyl, naphthyl, tetrahydronaphthyl, indenyl, indanyl, Pentalenyl, fluorenyl and the like, preferably phenyl.

A heterocyclic radical or ring (heterocyclyl) may be saturated, unsaturated or heteroaromatic and unsubstituted or substituted; it preferably contains one or more heteroatoms in the ring, preferably from the group N, O and S; it is preferably an aliphatic heterocyclyl radical having 3 to 7 ring atoms or a heteroaromatic radical having 5 or 6 ring atoms and contains 1, 2 or 3 heteroatoms. The heterocyclic radical may be, for example, a heteroaromatic radical or ring (heteroaryl), for example a mono-, bi- or polycyclic aromatic system in which at least one ring contains one or more heteroatoms, for example pyridyl, pyrimidinyl, pyridazinyl, pyrazinyl, triazinyl, Thienyl, thiazolyl, oxazolyl, furyl, pyrrolyl, pyrazolyl and imidazolyl, or is a partially or fully hydrogenated radical such as oxiranyl, oxetanyl, pyrrolidyl, piperidyl, piperazinyl, triazolyl, dioxolanyl, morpholinyl, tetrahydrofuryl. Preference is given to pyrimidinyl and triazinyl. As substituents for a substituted heterocyclic radical ge below called substituents in question, in addition also oxo. The oxo group may also occur on the hetero ring atoms, which may exist in different oxidation states, eg at N and S.

Substituted radicals, such as substituted hydrocarbon radicals, for example substituted alkyl, alkenyl, alkynyl, aryl, phenyl and benzyl, or substituted heterocyclyl or heteroaryl, represent, for example, a substituted radical derived from the unsubstituted radical, where the substituents are, for example, one or more, preferably 1, 2 or 3 3 radicals from the group halogen, alkoxy, haloalkoxy, alkylthio, hydroxy, amino, nitro, carboxy, cyano, azido, alkoxycarbonyl, alkylcarbonyl, formyl, carbamoyl, mono- and dialkylaminocarbonyl, substituted amino, such as acylamino, mono- and dialkylamino, and Alkylsulfinyl, haloalkylsulfinyl, alkylsulfonyl, haloalkylsulfonyl and, in the case of cyclic radicals, also alkyl and haloalkyl and said saturated hydrocarbon-containing radicals corresponding unsaturated aliphatic radicals, such as alkenyl, alkynyl, alkenyloxy, alkynyloxy, etc. For radicals with C atoms, those having 1 to 4 C atoms, in particular 1 or 2 C atoms, are preferred. As a rule, preference is given to substituents from the group halogen, for example fluorine and chlorine, (C ₁ -C ₄ ) alkyl, preferably methyl or ethyl, (C ₁ -C ₄ ) haloalkyl, preferably trifluoromethyl, (C ₁ -C ₄ ) alkoxy , preferably methoxy or ethoxy, (C ₁ -C ₄ ) haloalkoxy, nitro and cyano. Particularly preferred are the substituents methyl, methoxy and chlorine.

Optionally substituted phenyl is preferably phenyl which is unsubstituted or mono- or polysubstituted, preferably up to three times by identical or different radicals, preferably from the group halogen, (C ₁ -C ₄ ) -alkyl, (C ₁ -C ₄ ) -alkoxy, ( C ₁ -C ₄ ) haloalkyl, (C ₁ -C ₄ ) haloalkoxy and nitro, for example o-, m- and p-tolyl, dimethylphenyl, 2-, 3- and 4-chlorophenyl, 2-, 3- and 4-trifluoro- and trichlorophenyl, 2,4-, 3,5-, 2,5- and 2,3-dichlorophenyl, o-, m- and p-methoxyphenyl.

cycloalkyl is preferably a carbocyclic saturated ring system with 3-6 C atoms, e.g. Cyclopropyl, cyclobutyl, cyclopentyl or Cyclohexyl.

The carbon-containing radicals such as alkyl, alkoxy, haloalkyl, haloalkoxy, Alkylamino and alkylthio and the corresponding unsaturated and / or substituted radicals in the carbon skeleton in each case straight-chain or branched be. Unless specifically stated, these radicals are the low carbon skeletons, e.g. with 1 to 6 C-atoms or with unsaturated groups with 2 to 6 C atoms, preferred. Alkyl radicals, also in compound meanings such as alkoxy, haloalkyl, etc., mean e.g. Methyl, ethyl, n- or i-propyl, n-, i-, t- or 2-butyl, pentyls, hexyls, such as n-hexyl, i-hexyl and 1,3-dimethylbutyl, heptyls such as n-heptyl, 1-methylhexyl and 1,4-dimethylpentyl; Alkenyl and alkynyl radicals have the meaning the possible unsaturated corresponding to the alkyl radicals residues; Alkenyl means e.g. Allyl, 1-methylprop-2-en-1-yl, 2-methylprop-2-en-1-yl, But-2-en-1-yl, but-3-en-1-yl, 1-methylbut-3-en-1-yl and 1-methyl-but-2-en-1-yl; Alkynyl means e.g. Propargyl, but-2-yn-1-yl, but-3-yn-1-yl, 1-methyl-but-3-yn-1-yl.

Halogen is, for example, fluorine, chlorine, bromine or iodine. Haloalkyl, -alkenyl and -alkynyl by halogen, preferably by fluorine, chlorine and / or bromine, in particular by fluorine or chlorine, partially or completely substituted alkyl, alkenyl or alkynyl, for example CF ₃ , CHF ₂ , CH ₂ F, CF ₃ CF ₂ , CH ₂ FCHCl, CCl ₃ , CHCl ₂ , CH ₂ CH ₂ Cl; Haloalkoxy is, for example, OCF ₃ , OCHF ₂ , OCH ₂ F, CF ₃ CF ₂ O, OCH ₂ CF ₃ and OCH ₂ CH ₂ Cl; the same applies to haloalkenyl and other halogen-substituted radicals.

The herbicidal active ingredients a) from the series of sulfonamides are in the Oil suspension concentrates according to the invention generally in amounts of 0.01 to 50 wt.%, Preferably 0.1 to 30% by weight, in this case the indication "% by weight" here and in the total description, unless otherwise defined, relative to the relative Weight of the respective component based on the total weight the formulation.

When Component b) are safeners in the oil suspension concentrates according to the invention that are likely to cause damage to the crop reduce or avoid. Suitable safeners are e.g. from WO-A-96/14747 and the literature cited there. The safeners can in the organic solvent in suspended and / or dissolved Form, preferably in dissolved form Form present.

• 1) Verbindungen vom Typ der Dichlorphenylpyrazolin-3-carbonsäure (S1), vorzugsweise Verbindungen wie 1-(2,4-Dichlorphenyl)-5-(ethoxycarbonyl)-5-methyl-2-pyrazolin-3-carbonsäureethylester (S1-1, Mefenpyr-diethy), PM S. 781 – 782), und verwandte Verbindungen, wie sie in der WO 91/07874 beschrieben sind,
• 2) Derivate der Dichlorphenylpyrazolcarbonsäure, vorzugsweise Verbindungen wie 1-(2,4-Dichlorphenyl)-5-methyl-pyrazol-3-carbonsäureethylester (S1-2), 1-(2,4-Dichlorphenyl)-5-isopropyl-pyrazol-3-carbonsäureethylester (S1-3), 1-(2,4-Dichlorphenyl)-5-(1,1-dimethyl-ethyl)pyrazol-3-carbonsäureethyl-ester (S1-4), 1-(2,4-Dichlorphenyl)-5-phenyl-pyrazol-3-carbonsäureethylester (S1-5) und verwandte Verbindungen, wie sie in EP-A-333 131 und EP-A-269 806 beschrieben sind.
• 3) Verbindungen vom Typ der Triazolcarbonsäuren (S1), vorzugsweise Verbindungen wie Fenchlorazol, d.h. 1-(2,4-Dichlorphenyl)-5-trichlormethyl-(1H)-1,2,4-triazol-3-carbonsäureethylester (S1-6), und verwandte Verbindungen (siehe EP-A-174 562 und EP-A-346 620);
• 4) Verbindungen vom Typ der 5-Benzyl- oder 5-Phenyl-2-isoxazolin-3-carbonsäure, oder der 5,5-Diphenyl-2-isoxazolin-3-carbonsäure vorzugsweise Verbindungen wie 5-(2,4-Dichlorbenzyl)-2-isoxazolin-3-carbonsäureethylester (S1-7) oder 5-Phenyl-2-isoxazolin-3-carbonsäureethylester (S1-8) und verwandte Verbindungen, wie sie in WO 91/08202 beschrieben sind, bzw. der 5,5-Diphenyl-2-isoxazolin-carbonsäureethylester (S1-9, Isoxadifen-ethyl) oder -n-propylester (S1-10) oder der 5-(4-Fluorphenyl)-5-phenyl-2-isoxazolin-3- carbonsäureethylester (S1-11), wie sie in der Patentanmeldung (WO-A-95/07897) beschrieben sind.
• 5) Verbindungen vom Typ der 8-Chinolinoxyessigsäure (S2), vorzugsweise (5-Chlor-8-chinolinoxy)-essigsäure-(1-methyl-hex-1-yl)-ester (S2-1 Cloquintocet-mexyl, PM S. 263 – 264), (5-Chlor-8-chinolinoxy)-essigsäure-(1,3-dimethyl-but-1-yl)-ester (S2-2), (5-Chlor-8-chinolinoxy)-essigsäure-4-allyl-oxy-butylester (S2-3), (5-Chlor-8-chinolinoxy)-essigsäure-1-allyloxy-prop-2-ylester (S2-4), (5-Chlor-8-chinolinoxy)-essigsäureethylester (S2-5), (5-Chlor-8-chinolinoxy)-essigsäuremethylester (S2-6), (5-Chlor-8-chinolinoxy)-essigsäureallylester (S2-7), (5-Chlor-8-chinolinoxy)-essigsäure-2-(2-propyliden-iminoxy)-1-ethylester (S2-8), (5-Chlor-8-chinolinoxy)-essigsäure-2-oxo-prop-1-ylester (S2-9) und verwandte Verbindungen, wie sie in EP-A-86 750, EP-A-94 349 und EP-A-191 736 oder EP-A-0 492 366 beschrieben sind.
• 6) Verbindungen vom Typ der (5-Chlor-8-chinolinoxy)-malonsäure, vorzugsweise Verbindungen wie (5-Chlor-8-chinolinoxy)-malonsäurediethylester, (5-Chlor-8-chinolinoxy)-malonsäurediallylester, (5-Chlor-8-chinolinoxy)-malonsäure-methyl-ethylester und verwandte Verbindungen, wie sie in EP-A-0 582 198 beschrieben sind.
• 7) Wirkstoffe vom Typ der Phenoxyessig- bzw. -propionsäurederivate bzw. der aromatischen Carbonsäuren, wie z.B. 2,4-Dichlorphenoxyessigsäure(ester) (2,4-D), 4-Chlor-2-methyl-phenoxy-propionester (Mecoprop), MCPA oder 3,6-Dichlor-2-methoxy-benzoesäure(ester) (Dicamba).
• 8) Wirkstoffe vom Typ der Pyrimidine, wie „Fenclorim" (PM, S. 512-511) (= 4,6-Dichlor-2-phenylpyrimidin),
• 9) Wirkstoffe vom Typ der Dichloracetamide, die häufig als Vorauflaufsafener (bodenwirksame Safener) angewendet werden, wie z.B. „Dichlormid" (PM, S. 363-364) (= N,N-Diallyl-2,2-dichloracetamid), „R-29148" (= 3-Dichloracetyl-2,2,5-trimethyl-1,3-oxazolidon von der Firma Stauffer), „Benoxacor" (PM, s. 102-103) (= 4-Dichloracetyl-3,4-dihydro-3-methyl-2H-1,4-benzoxazin). „PPG-1292" (= N-Allyl-N[(1,3-dioxolan-2-yl)-methyl]dichloracetamid von der Firma PPG Industries), „DK-24" (= N-Allyl-N-[(allylaminocarbonyl)-methyl]-dichloracetamid von der Firma Sagro-Chem), „AD-67" oder „MON 4660" (= 3-Dichloracetyl-1-oxa-3-aza-spiro[4,5]decan von der Firma Nitrokemia bzw. Monsanto), „Dicyclonon" oder „BAS145138" oder „LAB145138" (= (= 3-Dichloracetyl-2,5,5-trimethyl-1,3-diazabiclyco[4.3.0]nonan von der Firma BASF) und „Furilazol" oder „MON 13900" (siehe PM, 637-638) (= (RS)-3-Dichloracetyl-5-(2-furyl)-2,2-dimethyloxazolidon)
• 10) Wirkstoffe vom Typ der Dichloracetonderivate, wie z.B. „MG 191" (CAS-Reg. Nr. 96420-72-3) (= 2-Dichlormethyl-2-methyl-1,3-dioxolan von der Firma Nitrokemia),
• 11) Wirkstoffe vom Typ der Oxyimino-Verbindungen, die als Saatbeizmittel bekannt sind, wie z.B. „Oxabetrinil" (PM, S. 902-903) (= (Z)-1,3-Dioxolan-2-ylmethoxyimino(phenyl)acetonitril), das als Saatbeiz-Safener gegen Schäden von Metolachlor bekannt ist, „Fluxofenim" (PM, S. 613-614) (= 1-(4-Chlorphenyl)-2,2,2-trifluor-1-ethanon-O-(1,3-dioxolan-2-ylmethyl)-oxim, das als Saatbeiz-Safener gegen Schäden von Metolachlor bekannt ist, und „Cyometrinil" oder „CGA-43089" (PM, S. 1304) (= (Z)-Cyanomethoxyimino (phenyl)acetonitril), das als Saatbeiz-Safener gegen Schäden von Metolachlor bekannt ist,
• 12) Wirkstoffe vom Typ der Thiazolcarbonsäureester, die als Saatbeizmittel bekannt sind, wie z.B. „Flurazol" (PM, S. 590-591) (= 2-Chlor-4-trifluormethyl-1,3-thiazol-5-carbonsäurebenzylester), das als Saatbeiz-Safener gegen Schäden von Alachlor und Metolachlor bekannt ist,
• 13) Wirkstoffe vom Typ der Napthalindicarbonsäurederivate, die als Saatbeizmittel bekannt sind, wie z.B. „Naphthalic anhydrid" (PM, S. 1342) (= 1,8-Naphthalindicarbonsäureanhydrid), das als Saatbeiz-Safener für Mais gegen Schäden von Thiocarbamatherbiziden bekannt ist,
• 14) Wirkstoffe vom Typ Chromanessigsäurederivate, wie z.B. „CL 304415" (CAS-Reg. Nr. 31541-57-8) (= 2-84-Carboxy-chroman-4-yl)-essigsäure von der Firma American Cyanamid),
• 15) Wirkstoffe, die neben einer herbiziden Wirkung gegen Schadpflanzen auch Safenerwirkung an Kulturpflanzen aufweisen, wie z.B. „Dimepiperate" oder „MY-93" (PM, S. 404-405) (= Piperidin-1-thiocarbonsäure-S-1-methyl-1-phenylethylester), „Daimuron" oder „SK 23" (PM, S. 330) (= 1-(1-Methyl-1-phenylethyl)-3-p-tolyl-harnstoff), „Cumyluron" = „JC-940" (= 3-(2-Chlorphenylmethyl)-1-(1-methyl-1-phenylethyl)-harnstoff, siehe JP-A-60087254), „Methoxyphenon" oder „NK 049" (= 3,3'-Dimethyl-4-methoxybenzophenon), „CSB" (= 1-Brom-4-(chlormethylsulfonyl)-benzol) (CAS-Reg. Nr. 54091-06-4 von Kumiai).

The following groups of compounds are suitable, for example, as safeners:

• 1) compounds of the dichlorophenylpyrazoline-3-carboxylic acid type (S1), preferably compounds such as ethyl 1- (2,4-dichlorophenyl) -5- (ethoxycarbonyl) -5-methyl-2-pyrazoline-3-carboxylate (S1-1, Mefenpyr-diethy), PM p. 781-782), and related compounds as described in WO 91/07874,
• 2) derivatives of dichlorophenylpyrazolecarboxylic acid, preferably compounds such as ethyl 1- (2,4-dichlorophenyl) -5-methyl-pyrazole-3-carboxylate (S1-2), 1- (2,4-dichlorophenyl) -5-isopropyl-pyrazole 3-carboxylic Acid ethyl ester (S1-3), 1- (2,4-dichlorophenyl) -5- (1,1-dimethyl-ethyl) -pyrazole-3-carboxylic acid ethyl ester (S1-4), 1- (2,4-dichlorophenyl) 5-phenyl-pyrazole-3-carboxylic acid ethyl ester (S1-5) and related compounds as described in EP-A-333,131 and EP-A-269,806.
• 3) compounds of the type of the triazolecarboxylic acids (S1), preferably compounds such as fenchlorazole, ie ethyl 1- (2,4-dichlorophenyl) -5-trichloromethyl- (1H) -1,2,4-triazole-3-carboxylate (S1-6 ), and related compounds (see EP-A-174 562 and EP-A-346 620);
• 4) compounds of the 5-benzyl- or 5-phenyl-2-isoxazoline-3-carboxylic acid type or of the 5,5-diphenyl-2-isoxazoline-3-carboxylic acid, preferably compounds such as 5- (2,4-dichlorobenzyl) Ethyl 2-isoxazoline-3-carboxylate (S1-7) or ethyl 5-phenyl-2-isoxazoline-3-carboxylate (S1-8) and related compounds as described in WO 91/08202 or 5,5 Diphenyl-2-isoxazoline-carboxylic acid ethyl ester (S1-9, isoxadifen-ethyl) or n-propyl ester (S1-10) or ethyl 5- (4-fluorophenyl) -5-phenyl-2-isoxazoline-3-carboxylate (S1 -11), as described in the patent application (WO-A-95/07897).
• 5) Compounds of the type of 8-quinolinoxyacetic acid (S2), preferably (5-chloro-8-quinolinoxy) -acetic acid (1-methyl-hex-1-yl) ester (S2-1 Cloquintocet-mexyl, PM S. 263-264), (5-chloro-8-quinolinoxy) -acetic acid (1,3-dimethyl-but-1-yl) ester (S2-2), (5-chloro-8-quinolinoxy) -acetic acid 4-allyl oxy-butyl ester (S2-3), (5-chloro-8-quinolinoxy) -acetic acid 1-allyloxy-prop-2-yl ester (S2-4), (5-chloro-8-quinolinoxy) - ethyl acetate (S2-5), (5-chloro-8-quinolinoxy) -acetic acid methyl ester (S2-6), (5-chloro-8-quinolinoxy) -acetic acid allyl ester (S2-7), (5-chloro-8-quinolinoxy) -acetic acid 2- (2-propylidene-iminoxy) -1-ethyl ester (S2-8), (5-chloro-8-quinolinoxy) -acetic acid 2-oxo-prop-1-yl ester (S2-9) and related Compounds as described in EP-A-86 750, EP-A-94 349 and EP-A-191 736 or EP-A-0 492 366.
• 6) compounds of the (5-chloro-8-quinolinoxy) -malonic acid type, preferably compounds such as diethyl (5-chloro-8-quinolinoxy) malonate, (5-chloro-8-quinolinoxy) malonate, (5-chloro-8-quinolinoxy) 8-quinolinoxy) -malonic acid methyl ethyl ester and related compounds as described in EP-A-0 582 198.
• 7) Active substances of the phenoxyacetic or propionic acid derivatives or of the aromatic carboxylic acids, for example 2,4-dichlorophenoxyacetic acid (ester) (2,4-D), 4-chloro-2-methylphenoxypropionic ester (mecoprop) , MCPA or 3,6-dichloro-2-methoxy-benzoic acid (ester) (Dicamba).
• 8) active substances of the pyrimidines type, such as "fenclorim" (PM, p. 512-511) (= 4,6-dichloro-2-phenylpyrimidine),
• 9) Dichloroacetamide-type drugs commonly used as pre-emergence safeners (soil-active safeners) such as "Dichlormid" (PM, pp. 363-364) (= N, N-diallyl-2,2-dichloroacetamide), "R -29148 "(= 3-dichloroacetyl-2,2,5-trimethyl-1,3-oxazolidone from Stauffer)," Benoxacor "(PM, see 102-103) (= 4-dichloroacetyl-3,4- dihydro-3-methyl-2H-1,4-benzoxazine). "PPG-1292" (= N-allyl-N [(1,3-dioxolan-2-yl) -methyl] dichloroacetamide from PPG Industries), "DK-24" (= N-allyl-N - [(allylaminocarbonyl) -methyl] -dichloroacetamide from Sagro-Chem), "AD-67" or "MON 4660" (= 3-dichloroacetyl-1-oxa) 3-aza-spiro [4,5] decane from Nitrokemia or Monsanto), "dicyclonone" or "BAS145138" or "LAB145138" (= (= 3-dichloroacetyl-2,5,5-trimethyl-1,3 diazabiclyco [4.3.0] nonane from BASF) and "furilazole" or "MON 13900" (see PM, 637-638) (= (RS) -3-dichloroacetyl-5- (2-furyl) -2, 2-dimethyloxazolidon)
• 10) active substances of the type of dichloroacetone derivatives, such as, for example, "MG 191" (CAS Reg. No. 96420-72-3) (= 2-dichloromethyl-2-methyl-1,3-dioxolane from Nitrokemia),
• 11) active substances of the type of oxyimino compounds known as seed dressings, such as "oxabetrinil" (PM, p. 902-903) (= (Z) -1,3-dioxolan-2-ylmethoxyimino (phenyl) acetonitrile) known as seed safener against damage by metolachlor, "Fluxofenim" (PM, p. 613-614) (= 1- (4-chlorophenyl) -2,2,2-trifluoro-1-ethanone-O- ( 1,3-dioxolan-2-ylmethyl) oxime, known as seed safener against damage by metolachlor, and "Cyometrinil" or "CGA-43089" (PM, p. 1304) (= (Z) -cyanomethoxyimino ( phenyl) acetonitrile), known as seed safener against damage from metolachlor,
• 12) active substances of the type of Thiazolcarbonsäureester, which are known as seed dressings, such as "flurazole" (PM, p. 590-591) (= 2-chloro-4-trifluoromethyl-1,3-thiazole-5-carboxylic acid benzyl ester), the is known as Saatbeiz-Safener against damage from alachlor and metolachlor,
• 13) Naphthalenedicarboxylic acid type active agents known as seed dressing agents, such as "naphthalic anhydride" (PM, p. 1342) (= 1,8-naphthalenedicarboxylic anhydride), which is known as a seed safener for corn against damage by thiocarbamate herbicides.
• 14) active substances of the type chromanacetic acid derivatives, such as "CL 304415" (CAS Reg. No. 31541-57-8) (= 2-84-carboxy-chroman-4-yl) -acetic acid from American Cyanamid),
• 15) active substances which, in addition to a herbicidal activity against harmful plants, also have safener action on crop plants, for example "dimepiperate" or "MY-93" (PM, pp. 404-405) (= piperidine-1-thiocarboxylic acid S-1-methyl 1-phenylethyl ester), "daimurone" or "SK 23" (PM, p. 330) (= 1- (1-methyl-1-phenylethyl) -3-p-tolyl-urea), "cumyluron" = "JC -940 "(= 3- (2-chlorophenylmethyl) -1- (1-methyl-1-phenylethyl) urea, see JP-A-60087254)," methoxyphenone "or" NK 049 "(= 3,3'- Dimethyl-4-methoxybenzophenone), "COD" (= 1-bromo-4- (chloromethylsulfonyl) -benzene) (CAS Reg. No. 54091-06-4 from Kumiai).

In the oil suspension concentrates according to the invention the safeners are generally present in amounts of from 0.1 to 60% by weight, in particular from 2 to 40% by weight.

The weight ratio Component a) to component b) can be used in a wide range vary, and is generally between 1: 100 and 100: 1, preferably between 1:10 and 10: 1.

When optional agrochemical active substances e) can be used, for example, by the Components a) and b) various agrochemical active substances such as Herbicides, fungicides, insecticides, plant growth regulators and may be included. The agrochemical active ingredients e) can be used in the organic solvent in suspended and / or dissolved Form present.

• A) Herbizide vom Typ der Phenoxyphenoxy- und Heteroaryloxyphenoxycarbonsäure-Derivate, wie A1) Phenoxyphenoxy- und Benzyloxyphenoxy-carbonsäure-Derivate, z.B. 2-(4-(2,4-Dichlorphenoxy)-phenoxy)-propionsäuremethylester (Diclofop-methyl), 2-(4-(4-Brom-2-chlorphenoxy)phenoxy)propionsäuremethylester (DE-A 26 01 548), 2-(4-(4-Brom-2-fluorphenoxy)phenoxy)propionsäuremethylester (US-A 4,808,750), 2-(4-(2-Chlor-4-trifluormethylphenoxy)phenoxy)propionsäuremethylester (DE-A 24 33 067), 2-(4-(2-Fluor-4-trifluormethylphenoxy)phenoxy)propionsäuremethylester (US-A 4,808,750), 2-(4-(2,4-Dichlorbenzyl)phenoxy)propionsäuremethylester (DE-A 24 17 487), 4-(4-(4-Trifluormethylphenoxy)phenoxy)pent-2-en-säureethylester, 2-(4-(4-Trifluormethylphenoxy)phenoxy)propionsäuremethylester (DE-A 24 33 067); A2) "Einkernige" Heteroaryloxyphenoxy-alkancarbonsäure-Derivate, z.B. 2-(4-(3,5-Dichlorpyridyl-2-oxy)phenoxy)propionsäureethylester (EP-A 0 002 925), 2-(4-(3,5-Dichlorpyridyl-2-oxy)phenoxy)propionsäurepropargylester (EP-A 0 003 114), 2-(4-(3-Chlor-5-trifluormethyl-2-pyridyloxy)phenoxy)propionsäure-methylester (EP-A 0 003 890), 2-(4-(3-Chlor-5-trifluormethyl-2-pyridyloxy)phenoxy)propionsäureethylester (EP-A 0 003 890), 2-(4-(5-Chlor-3-Fuor-2-pyridyloxy)phenoxy)propionsäurepropargylester (EP-A 0 191 736), 2-(4-(5-Trifluormethyl-2-pyridyloxy)phenoxy)propionsäurebutylester (Fluazifop-butyl); A3) "Zweikernige" Heteroaryloxyphenoxy-alkancarbonsäure-Derivate, z.B. 2-(4-(6-Chlor-2-chinoxalyloxy)phenoxy)propionsäuremethylester und -ethylester (Quizalofopmethyl und Quizalofopethyl), 2-(4-(6-Fluor-2-chinoxalyloxy)phenoxy)propionsäuremethylester (s. J. Pest. Sci. Vol. 10, 61 (1985)), 2-(4-(6-Chlor-2-chinoxalyloxy)phenoxy)propionsäure-2-isopropylidenaminooxyethylester (Propaquizafop), 2-(4-(6-Chlorbenzoxazol-2-yl-oxy)phenoxy)propionsäureethylester (Fenoxapropethyl) und dessen D(+) Isomer (Fenoxaprop-P-ethyl, EX) und 2-(4-(6-Chlorbenzthiazol-2-yloxy)phenoxy)propionsäureethylester (DE-A 26 40 730), 2-(4-(6-Chlorchinoxalyloxy)phenoxy)propionsäure-tetrahydro-2-furylmethylester (EP-A 0 323 727);
• B) Chloracetanilide, z.B. N-Methoxymethyl-2,6-diethyl-chloracetanilid (Alachlor), N-(3-Methoxyprop-2-yl)-2-methyl-6-ethyl-chloracetanilid (Metolachlor), N-(3-Methyl-1,2,4-oxadiazol-5-yl-methyl)-chloressigsäure-2,6-dimethylanilid, N-(2,6-Dimethylphenyl)-N-(1-pyrazolylmethyl)-chloressigsäureamid (Metazachlor);
• C) Thiocarbamate, z.B. S-Ethyl-N,N-dipropylthiocarbamat (EPTC), S-Ethyl-N,N-diisobutylthiocarbamat (Butylate);
• D) Cyclohexandionoxime, z.B. 3-(1-Allyloxyiminobutyl)-4-hydroxy-6,6-dimethyl-2-oxocyclohex-3-encarbonsäuremethylester, (Alloxydim), 2-(1-Ethoxyiminobutyl)-5-(2-ethylthiopropyl)-3-hydroxy-cyclohex-2-en-1-on (Sethoxydim), 2-(1-Ethoxyiminobutyl)-5-(2-phenylthiopropyl)-3-hydroxy-cyclohex-2-en-1-on (Cloproxydim), 2-(1-(3-Chlorallyloxy)iminobutyl)-5-(2-ethylthiopropyl)-3-hydroxy-cyclohex-2-en-1-on, 2-(1-(3-Chlorallyloxy)iminopropyl)-5-(2-ethylthiopropyl)-3-hydroxy-cyclohex-2-en-1-on (Clethodim), 2-(1-Ethoxyiminobutyl)-3-hydroxy-5-(thian-3-yl)-cyclohex-2-enon (Cycloxydim), 2-(1-Ethoxyiminopropyl)-5-(2,4,6-trimethylphenyl)-3-hydroxy-cyclohex-2-en-1-on (Tralkoxydim);
• E) Benzoylcyclohexandione, z.B. 2-(2-Chlor-4-methylsulfonylbenzoyl)-cyclohexan-1,3-dion (SC-0051, EP-A 0 137 963), 2-(2-Nitrobenzoyl)-4,4-dimethyl-cyclohexan-1,3-dion (EP-A 0 274 634), 2-(2-Nitro-4-methylsulfonylbenzoyl)-4,4-dimethylcyclohexan-1,3-dion (WO 91/13548, Mesotrione);
• F) S-(N-Aryl-N-alkyl-carbamoylmethyl)-dithiophosphonsäureester, wie S-[N-(4-Chlorphenyl)-N-isopropyl-carbamoylmethyl]-O,O-dimethyl-dithiophosphat (Anilophos).
• G) Alkylazine, z.B. wie beschrieben in WO-A 97/08156, WO-A-97/31904, DE-A-19826670, WO-A-98/15536, WO-A-8/15537, WO-A-98/15538, WO-A-98/15539 sowie auch DE-A-19828519, WO-A-98/34925, WO-A-98/42684, WO-A-99/18100, WO-A-99/19309, WO-A-99/37627 und WO-A-99/65882, vorzugsweise solche der Formel (G)
  
  worin R^X (C₁-C₄)-Alkyl oder (C₁-C₄)-Haloalkyl; R^Y (C₁-C₄)-Alkyl, (C₃-C₆)-Cycloalkyl oder (C₃-C₆)-Cycloalkyl-(C₁-C₄)-Alkyl und A -CH₂-, -CH₂-CH₂-, -CH₂-CH₂-CH₂-, -O-, -CH_2–CH₂-O-, -CH₂-CH₂-CH₂-O- bedeuten, besonders bevorzugt solche der Formel G1-G7
  
  
• H) Phosphor-haltige Herbizide, z.B. vom Glusosinate-Typ wie Glufosinate im engeren Sinne, d. h. D,L-2-Amino-4-[hydroxy(methyl)phosphinyl]-butansäure, Glufosinate-monoammoniumsalz, L-Glufosinate, L- oder (2S)-2-Amino-4-[hydroxy(methyl)phosphinyl]-butansäure, L-Glufosinate-monoammoniumsalz oder Bialaphos (oder Bilanafos), d.h. L-2-Amino-4-[hydroxy(methyl)phosphinyl]-butanoyl-L-alanyl-L-alanin, insbesondere dessen Natriumsalz, oder vom Glyphosate-Typ wie Glyphosate, d. h. N-(Phosphonomethyl)-glycin, Glyphosate-monoisopropylammoniumsalz, Glyphosate-natriumsalz, oder Sulfosate, d. h. N-(Phosphonomethyl)-glycin-trimesiumsalz = N-(Phosphonomethyl)-glycintrimethylsulfoxoniumsalz.

Suitable active ingredients which are different from components a) and b) and may be optionally contained as component e) in the oil suspension concentrates according to the invention are preferably herbicidally active compounds, for example:

• A) herbicides of the phenoxyphenoxy- and heteroaryloxyphenoxycarboxylic acid-type derivatives, such as A1) phenoxyphenoxy- and benzyloxyphenoxy-carboxylic acid derivatives, for example methyl 2- (4- (2,4-dichlorophenoxy) -phenoxy) -propionate (diclofop-methyl), 2 - (4- (4-bromo-2-chlorophenoxy) phenoxy) propionic acid methyl ester (DE-A 26 01 548), 2- (4- (4-bromo-2-fluorophenoxy) phenoxy) propionic acid methyl ester (US Pat. No. 4,808,750), 2 - (4- (2-chloro-4-trifluoromethylphenoxy) phenoxy) propionate (DE-A 24 33 067), 2- (4- (2-fluoro-4-trifluoromethylphenoxy) phenoxy) propionate (US Pat. No. 4,808,750), 2 - (4- (2,4-dichlorobenzyl) phenoxy) propionate (DE-A 24 17 487), 4- (4- (4-trifluoromethylphenoxy) phenoxy) pent-2-enoic acid ethyl ester, 2- (4- (4 Trifluoromethylphenoxy) phenoxy) propionic acid methyl ester (DE-A 24 33 067); A2) "mononuclear" heteroaryloxyphenoxyalkanecarboxylic acid derivatives, eg ethyl 2- (4- (3,5-dichloropyridyl-2-oxy) phenoxy) propionate (EP-A 0 002 925), 2- (4- (3,5-) Dichloropyridyl-2-oxy) phenoxy) propionic acid propargyl ester (EP-A 0 003 114), methyl 2- (4- (3-chloro-5-trifluoromethyl-2-pyridyloxy) phenoxy) propionate (EP-A 0 003 890), Ethyl 2- (4- (3-chloro-5-trifluoromethyl-2-pyridyloxy) phenoxy) propionate (EP-A 0 003 890), 2- (4- (5-chloro-3-fluoro-2-pyridyloxy) phenoxy) propionic acid propargyl ester (EP-A 0 191 736), 2- (4- (5-trifluoromethyl-2-pyridyloxy) phenoxy) -propionic acid butyl ester (fluazifop-butyl); A3) "binuclear" heteroaryloxyphenoxyalkanecarboxylic acid derivatives, eg methyl 2- (4- (6-chloro-2-quinoxalyloxy) phenoxy) propionate and ethyl ester (quizalofopmethyl and quizalofopethyl), 2- (4- (6-fluoro-2-) quinoxalyloxy) phenoxy) propionic acid methyl ester (see J. Pest Sci., vol., 10, 61 (1985)), 2- (4- (6-chloro-2-quinoxalyloxy) phenoxy) propionic acid 2-isopropylideneaminooxyethyl ester (propaquizafop), 2 Ethyl (4- (6-chlorobenzoxazol-2-yl-oxy) -phenoxy) -propionate (fenoxapropethyl) and its D (+) isomer (fenoxaprop-P-ethyl, EX) and 2- (4- (6-chlorobenzothiazole-2-) yloxy) phenoxy) propionate (DE-A 26 40 730), 2- (4- (6-chloroquinoxalyloxy) phenoxy) propionic acid tetrahydro-2-furylmethyl ester (EP-A 0 323 727);
• B) Chloroacetanilides, eg N-methoxymethyl-2,6-diethyl-chloroacetanilide (alachlor), N- (3-methoxyprop-2-yl) -2-methyl-6-ethyl-chloroacetanilide (metolachlor), N- (3 Methyl-1,2,4-oxadiazol-5-ylmethyl) -chloroacetic acid-2,6-dimethylanilide, N- (2,6-dimethylphenyl) -N- (1-pyrazolylmethyl) -chloroacetic acid amide (metazachlor);
• C) thiocarbamates, eg S-ethyl-N, N-dipropylthiocarbamate (EPTC), S-ethyl-N, N-diisobutylthiocarbamate (butylates);
• D) cyclohexanedione oximes, eg methyl 3- (1-allyloxyiminobutyl) -4-hydroxy-6,6-dimethyl-2-oxocyclohex-3-enecarboxylate, (alloxydim), 2- (1-ethoxyiminobutyl) -5- (2-ethylthiopropyl) 3-hydroxycyclohex-2-en-1-one (sethoxydim), 2- (1-ethoxyiminobutyl) -5- (2-phenylthiopropyl) -3-hydroxycyclohex-2-en-1-one (cloproxydime) , 2- (1- (3-Chloroallyloxy) iminobutyl) -5- (2-ethylthiopropyl) -3-hydroxycyclohex-2-en-1-one, 2- (1- (3-chloroallyloxy) iminopropyl) -5 - (2-ethylthiopropyl) -3-hydroxycyclohex-2-en-1-one (clethodim), 2- (1-ethoxyiminobutyl) -3-hydroxy-5- (thian-3-yl) cyclohex-2- enone (cycloxydim), 2- (1-ethoxyiminopropyl) -5- (2,4,6-trimethylphenyl) -3-hydroxycyclohex-2-en-1-one (tralkoxydim);
• E) Benzoylcyclohexanediones, for example 2- (2-chloro-4-methylsulfonylbenzoyl) -cyclohexane-1,3-dione (SC-0051, EP-A 0 137 963), 2- (2-nitrobenzoyl) -4,4-dimethyl cyclohexane-1,3-dione (EP-A 0 274 634), 2- (2-nitro-4-methylsulfonylbenzoyl) -4,4-dimethylcyclohexane-1,3-dione (WO 91/13548, Mesotrione);
• F) S- (N-aryl-N-alkyl-carbamoylmethyl) -dithiophosphonic acid esters, such as S- [N- (4-chlorophenyl) -N-isopropyl-carbamoylmethyl] -O, O-dimethyl-dithiophosphate (anilophos).
• G) Alkylazines, for example as described in WO-A 97/08156, WO-A-97/31904, DE-A-19826670, WO-A-98/15536, WO-A-8/15537, WO-A-98 / 15538, WO-A-98/15539 and also DE-A-19828519, WO-A-98/34925, WO-A-98/42684, WO-A-99/18100, WO-A-99/19309, WO-A-99/37627 and WO-A-99/65882, preferably those of the formula (G)
  
  wherein R is ^X (C ₁ -C ₄ ) alkyl or (C ₁ -C ₄ ) haloalkyl; R ^{Y is} (C ₁ -C ₄ ) -alkyl, (C ₃ -C ₆ ) -cycloalkyl or (C ₃ -C ₆ ) -cycloalkyl- (C ₁ -C ₄ ) -alkyl and A is -CH ₂ -, -CH ₂ -CH ₂ -, -CH ₂ -CH ₂ -CH ₂ -, -O-, -CH ₂ CH ₂ -O-, -CH ₂ -CH ₂ -CH ₂ -O-, particularly preferably those of the formula G1-G7
  
  
• H) Phosphorus-containing herbicides, for example of the glusosinate type such as glufosinate in the strict sense, ie, D, L-2-amino-4- [hydroxy (methyl) phosphinyl] butanoic acid, glufosinate monoammonium salt, L-glufosinate, L- or (2S) -2-amino-4- [hydroxy (methyl) phosphinyl] butanoic acid, L-glufosinate monoammonium salt or bialaphos (or bilanafos), ie L-2-amino-4- [hydroxy (methyl) phosphinyl] butanoyl L-alanyl-L-alanine, in particular its sodium salt, or of the glyphosate type, such as glyphosate, ie N- (phosphonomethyl) glycine, glyphosate monoisopropylammonium salt, glyphosate sodium salt, or sulfosates, ie N- (phosphonomethyl) -glycine trimesium salt = N- (phosphonomethyl) glycine trimethylsulfoxonium salt.

The For example, herbicides of Groups A to H are from the above, respectively mentioned writings and from "The Pesticide Manual ", 12th edition, 2000, The British Crop Protection Council, "Agricultural Chemicals Book II - Herbicides - ", by W. T. Thompson, Thompson Publications, Fresno CA, USA 1990 and "Farm Chemicals Handbook '90", Master Publishing Company, Willoughby OH, USA, 1990.

Optional agrochemical active compounds (e) which are different from components (a) and (b) are, for example, the following known active compounds for the oil suspension concentrates according to the invention, as described, for example, in Weed Research 26, 441-445 (1986), or The Pesticide Manual, 12th edition, The British Crop Protection Council, 2000, and references cited therein, eg, in mixture formulations or as a tank mixing partner. The compounds are identified either by the "common name" according to the International Organization for Standardization (ISO) or by the chemical name, if appropriate together with a customary code number, and always include all forms of application, such as Acids, salts, esters and isomers such as stereoisomers and optical isomers: acetochlor; acifluorfen; aclonifen; AKH 7088, ie methyl [[[1- [5- [2-chloro-4- (trifluoromethyl) phenoxy] -2-nitrophenyl] -2-methoxyethylidene] amino] oxy] acetic acid and acetic acid; alachlor; alloxydim; ametryn; amitrol; AMS, ie ammonium sulfamate; anilofos; asulam; atrazine; azafenidines (DPX-R6447), aziprotryn; barban; BAS 516H, ie 5-fluoro-2-phenyl-4H-3,1-benzoxazin-4-one; benazolin; benfluralin; benfuresate; bensulide; bentazone; benzofluor; benzoylprop-ethyl; benzthiazuron; bialaphos; bifenox; bispyribac sodium (KIH-2023), bromacil; bromobutide; bromofenoxim; bromoxynil, in particular bromoxyniloctanoate and bromoxynilheptanoate; butachlor; butamifos; butenachlor; buthidazole; butraline; butroxydim (ICI-0500), butylate; cafenstrole (CH-900); carbetamide; cafentrazone; CDAA, ie 2-chloro-N, N-di-2-propenylacetamide; CDEC, ie diethyldithiocarbamic acid 2-chloroallyl ester; chlomethoxyfen; chloramben; cloransulam-methyl (XDE-565), chloroazifop-butyl, chlorobromuron; chlorbufam; chlorfenac; chlorflurenol-methyl; chloridazon; chlornitrofen; chlorotoluron; chloroxuron; chlorpropham; chlorthal-dimethyl; chlorthiamid; cinidon-ethyl, cinmethylin; clethodim; clodinafop and its ester derivatives (eg clodinafop-propargyl); clomazone; clomeprop; cloproxydim; clopyralid; cumyluron (JC 940); cyanazine; cycloate; cycloxydim; cycluron; cyhalofop and its ester derivatives (eg, butyl ester, DEH-112); cyperquat; cyprazine; cyprazole; 2,4-D; 2,4-DB; dalapon; desmedipham; Desmetryn; di-allate; dicamba; dichlobenil; dichloroprop; diclofop and its esters such as diclofop-methyl; diclosulam (XDE-564), diethatyl; difenoxuron; difenzoquat; diflufenican; diflufenzopyr sodium (SAN-835H), dimefuron; dimethachlor; dimethametryn; dimethenamid (SAN-582H); Dimidazone, 5- (4,6-dimethylpyrimidin-2-yl-carbamoylsulfamoyl) -1- (2-pyridyl) -pyrazole-4-carboxylic acid, methyl ester (NC-330); triaziflam (IDH-1105), cinosulfone; dimethipine, dinitramine; dinoseb; dinoterb; diphenamid; dipropetryn; diquat; dithiopyr; diuron; DNOC; eglinazine-ethyl; EL 177, ie 5-cyano-1- (1,1-dimethylethyl) -N-methyl-1H-pyrazole-4-carboxamide; endothal; indanofan (MK-243), EPTC; esprocarb; ethalfluralin; Ethidimuron; ethiozin; ethofumesate; F5231, ie N- [2-chloro-4-fluoro-5- [4- (3-fluoropropyl) -4,5-dihydro-5-oxo-1H-tetrazol-1-yl] -phenyl] -ethanesulfonamide; ethoxyfen and its esters (eg ethyl ester, HN-252); etobenzanide (HW 52); 3- (4-ethoxy-6-ethyl-1,3,5-triazin-2-yl) -1- (2,3-dihydro-1,1-dioxo-2-methylbenzo [b] thiophen-7-sulfonyl ) urea (EP-A 079 683); 3- (4-ethyl-6-methoxy-1,3,5-triazin-2-yl) -1- (2,3-dihydro-1,1-dioxo-2-methylbenzo [b] thiophen-7-sulfonyl ) urea (EP-A 079 683); fenoprop; clomazone, fenoxaprop and fenoxaprop-P and their esters, eg fenoxaprop-P-ethyl and fenoxaprop-ethyl; butroxydimfenuron; flamprop-methyl; flufenacet (BAY-FOE-5043), fluazifop and fluazifop-P and their esters, eg fluazifop-butyl and fluazifop-P-butyl, florasulam (DE-570); fluchloralin; flumetsulam; fluometuron; flumiclorac and its esters (eg, pentyl ester, S-23031); flumioxazine (S-482); flumipropyn; flupoxam (KNW-739); fluorodifen; fluoroglycofen-ethyl; flupropacil (UBIC-4243); fluridone; flurochloridone; fluroxypyr; flurtamone; fluthiacet-methyl (KIH-9201), fomesafen; fosamine; furyloxyfen; glufosinate; glyphosate; halo safen; halosulfuron and its esters (eg, methyl ester, NC-319); haloxyfop and its esters; haloxyfop-P (= R-haloxyfop) and its esters; hexazinone; imazamethabenz-methyl; imazamox (AC-299263), imazapyr; imazaquin and salts such as the ammonium salt; imazapic; imazethapyr; imazosulfuron; ioxynil; isocarbamid; isopropalin; isoproturon; isouron; isoxaben; isoxapyrifop; karbutilate; lactofen; lenacil; linuron; MCPA; MCPB; mecoprop; mefenacet; mefluidide; metamitron; metazachlor; methabenzthiazuron; metam; methazole; methoxyphenone; methyldymron; metobenzuron, mesosulfuron-methyl, mesosulfuron-methyl (WO 95/10507); metobromuron; metolachlor; S-metolachlor, metosulam (XRD 511); metoxuron; metribuzin; maleic hydrazides; molinate; monalide; monocarbamide dihydrogen sulfates; monolinuron; monuron; MT 128, ie 6-chloro-N- (3-chloro-2-propenyl) -5-methyl-N-phenyl-3-pyridazineamine; MT 5950, ie N- [3-chloro-4- (1-methylethyl) phenyl] -2-methylpentanamide; foramsulfuron (WO 95/01344); naproanilide; napropamide; naptalam; NC 310, ie 4- (2,4-dichlorobenzoyl) -1-methyl-5-benzyloxypyrazole; neburon; nipyraclophen; nitralin; nitrofen; nitrofluorfen; norflurazon; orbencarb; oryzalin; oxadiargyl (RP-020630); oxadiazon; oxaziclomefones (MY-100), oxyfluorfen; paraquat; pebulate; pendimethalin; pentoxazone (KPP-314), perfluidone; phenisopham; phenmedipham; picloram; piperophos; pyributicarb; pirifenop-butyl; pretilachlor; procyazine; prodi amines; profluralin; proglinazine-ethyl; prometon; prometryne; propachlor; propanil; propaquizafop and its esters; propazine; propham; propisochlor; Propyzamide; prosulfalin; prosulfocarb; prynachlor; pyraflufen-ethyl (ET-751), chloridazon; pyrazoxyfen; pyribenzoxime, pyridates; pyriminobac-methyl (KIH-6127), pyrithiobac (KIH-2031); pyroxofop and its esters (eg propargyl esters); quinclorac; quinmerac; quizalofop, quizalofop and quizalofop-P and their ester derivatives eg quizalofop-ethyl; quizalofop-P-tefuryl and -ethyl; S 275, ie 2- [4-chloro-2-fluoro-5- (2-propynyloxy) -phenyl] -4,5,6,7-tetrahydro-2H-indazole; secbumeton; sethoxydim; siduron; simazine; simetryn; SN 106279, ie 2 - [[7- [2-chloro-4- (trifluoromethyl) phenoxy] -2-naphthalenyl] oxy] propanoic acid and methyl ester; flazasulfuron (FMC-97285, F-6285); sulfazuron; glyphosate trimesium (ICI-A0224); TCA; tebutam (GCP-5544); tebuthiuron; tepral oxydim (BAS-620H), terbacil; terbucarb; terbuchlor; terbumeton; Terbuthylazine; terbutryn; TFH 450, ie, N, N-diethyl-3 - [(2-ethyl-6-methylphenyl) sulfonyl] -1H-1,2,4-triazole-1-carboxamide; thenylchlor (NSK-850); thiazafluron; thiazopyr (Mon-13200); thidiazimin (SN-124085); thiobencarb; tiocarbazil; tralkoxydim; tri-allate; triazofenamide; triclopyr; tridiphane; trietazine; trifluralin; trimeturon; tsitodef; vernolate; WL 110547, ie 5-phenoxy-1- [3- (trifluoromethyl) -phenyl] -1H-tetrazole; UBH-509; D-489; LS 82-556; KPP-300; KPP-421, MT-146, NC-324; butenachlor (KH-218); DPX-N8189; haloxyfop-etotyl (DOWCO-535); DK-8910; flumioxazin (V-53482); PP-600; MBH-001, amicarbazone, aminopyralid, beflubutamide, benzobicyclone, benzofenap, benzfendizone, butafenacil, chlorfenprop, cloprop, daimuron, dichlorprop-P, dimepipeate, dimethenamid-P, fentrazamide, flamprop-M, fluazolate, indanofan, isoxachlortole, isoxaflutole, MCPA thioethyl, mecoprop-P, mesotrione, metamifop, penoxsulam, pethoxamide, picolinafen, profluazole, profoxydim, pyraclonil, pyrazolynate, pyridafol, pyriftalid, sulcotrione, thidiazuron.

preferred Components e) are bromoxynil (E1) in all its forms of use including the salts and esters, e.g. Bromoxyniloctanoate (E1.1), Bromoxynil heptanoate (E1.2), bromoxynil butyrate (E1.3), bromoxynil sodium (E1.4) and Bromoxynil Potassium (E1.5); 2,4-D (E2) in all its forms of application including the salts and esters, e.g. 2,4-D-butyl (E2.1), 2,4-D-butyl (E2.2), 2,4-D-dimethylammonium (E2.3), 2,4-D-diethanolamine (E2.4), 2,4-D-2-ethylhexyl (E2.5), 2,4-D-isooctyl (E2.6), 2,4-D-isopropyl (E2.7), 2,4-D-sodium (E2.8) and 2,4-D-triethanolamine (E2.9); Dicamba (E3) in all its forms of application including the salts and esters, e.g. Dicamba sodium (E3.1), dicamba potassium (E3.2) and dicamba dimethyl ammonium (E3.3); Fenoxaprop (E4) in all its application forms including the esters, e.g. Fenoxaprop-ethyl (E4.1) and fenoxaprop-P-ethyl (E4.2); Fluroxypyr (E5) in all its application forms including salts and esters, e.g. Fluroxypyr-meptyl (E5.1) and fluroxypyr-2-butoxy-1-methylethyl (E5.2); MCPA (E6) in all its application forms including salts and esters, e.g. MCPA sodium (E6.1), MCPA potassium (E6.2), MCPA-2-ethylhexyl (E6.3), MCPA-butotyl (E6.4) and MCPA-dimethylammonium (E6.5).

So far in the oil suspension concentrates according to the invention agrochemical active ingredients e) are included, their weight fraction is 0.5 to 50 wt .-%, in particular 3 to 20 wt .-%.

Of the in the oil suspension concentrates according to the invention total active substance content (sum of component a) + b) + e)) is generally between 1 and 80 wt.%, In particular between 3 and 60% by weight.

• 1) Kohlenwasserstoffe, die unsubstituiert oder substituiert sein können, z.B. 1a) aromatische Kohlenwasserstoffe, z.B. – ein- oder mehrfach alkyl-substituierte Benzole wie Toluol, Xylole, Mesitylen, Ethylbenzol, oder – ein- oder mehrfach alkyl-substituierte Naphthaline wie 1-Methylnaphthalin, 2-Methylnaphthalin oder Dimethylnaphthalin, oder – andere vom Benzol abgeleitete aromatische Kohlenwasserstoffe, wie Indan oder Tetralin^®, oder – Gemische hieraus, 1b) aliphatische Kohlenwasserstoffe, z.B. – lineare oder verzweigte Aliphaten, z.B. der allgemeinen Formel C_nH_2n+2, wie Pentan, Hexan, Octan, 2-Methylbutan oder 2,2,4-Trimethylpentan, oder – cyclische, gegebenenfalls alkyl-substituierte Aliphaten, wie Cyclohexan oder Methylcyclopentan, oder – Gemische hieraus, wie Lösungsmittel der Exxsol^®D-Reihe, Isopar^®-Reihe oder Bayo^®-Reihe z.B. Bayol^®82 (ExxonMobil Chemicals) oder der Isane^®IP-Reihe oder Hydroseal^®G-Reihe (TotalFinaElf), 1c) Gemische von aromatischen und aliphatischen Kohlenwasserstoffen, wie Lösungsmittel der Solvesso^®-Reihe z.B. Solvesso^®100, Solvesso^®150 oder Solvesso^®200 (ExxonMobil Chemicals), der Solvarex^®/Solvaro^®-Reihe (TotalFinaElf) oder der Caromax^®-Reihe z.B. Caromax^®28 (Petrochem Carless), oder 1d) halogenierte Kohlenwasserstoffe wie halogenierte aromatische und aliphatische Kohlenwasserstoffe, wie Chlorbenzol oder Methylenchlorid, oder
• 2) aprotische, polare Lösungsmittel, wie Ether, Ester von C₁-C₉-Alkansäuren, die mono-, di- oder polyfunktional sein können, wie deren Mono-, Di- oder Triester, z.B. mit C₁-C₁₈-Alkylalkoholen, Ketone mit geringer Tautomerietendenz, Phophorsäureester, Amide, Nitrile oder Sulfone, z.B. Diisobutyladipat, Rhodiasolv^® RPDE (Rhodia), Cyclohexanon, Jeffsol^®PC (Huntsman), γ-Butyrolacton, N-Methylpyrrolidon, Dimethylsulfoxid, Acetonitril, Tributylphosphatam oder Hostarex^®PO-Reihe (Clariant), oder
• 3) Fettsäureester, z.B. natürlichen Ursprungs, z.B. natürliche Öle wie tierische Öle oder Pflanzenöle, oder synthetischen Ursprungs, z.B. Edenor^®-Reihe z.B. Edenor^®MEPa oder Edenor^®MESU oder Agnique^®ME-Reihe oder Agnique^®AE-Reihe (Cognis), Salim^®ME-Reihe (Salim), Radia^®-Reihe z.B. Radia^®30167 (ICI), Prilube^®-Reihe z.B. Prilube^®1530 (Petrofina), Stepan^®C-Reihe (Stepan) oder Witconol^®23-Reihe (Witco). Die Fettsäureester sind bevorzugt Ester von C₁₀-C₂₂-, vorzugsweise C₂-C₂₀-Fettsäuren. Die C₁₀-C₂₂-Fettsäureester sind beispielsweise Ester ungesättigter oder gesättigter C₁₀-C₂₂-Fettsäuren, insbesondere mit gerader Kohlenstoffatomzahl, z.B. Erucasäure, Laurinsäure, Palmitinsäure und insbesondere C₁₈-Fettsäuren wie Stearinsäure, Ölsäure, Linolsäure oder Linolensäure. Beispiele für Fettsäureester wie C₁₀-C₂₂-Fettsäure-Ester sind Glycerin- und Glykolester von Fettsäuren wie C₁₀-C₂₂-Fettsäuren oder deren Umesterungsprodukte, z.B. Alkyl-Fettsäureester wie C₁-C₂₀-Alkyl-C₁₀-C₂₂-Fettsäure-Ester, wie sie z.B. durch Umesterung der vorgenannten Glycerin- oder Glykol-Fettsäureester wie C₁-C₂₂-Fettsäure-Ester mit C₁-C₂₀-Alkoholen (z.B. Methanol, Ethanol, Propanol oder Butanol) erhalten werden können. Die Umesterung kann nach bekannten Methoden erfolgen, wie sie z.B. beschrieben sind im Römpp Chemie Lexikon, 9. Auflage, Band 2, Seite 1343, Thieme Verlag Stuttgart. Als Alkyl-Fettsäureester wie C₁-C₂₀-Alkyl-C₁₀-C₂₂-Fettsäure-Ester bevorzugt sind Methylester, Ethylester, Propylester, Butylester, 2-ethyl-hexylester und Dodecylester. Als Glykol- und Glycerin-Fettsäureester wie C₁₀-C₂₂-Fettsäure-Ester bevorzugt sind die einheitlichen oder gemischten Glykolester und Glycerinester von C₁₀-C₂₂-Fettsäuren, insbesondere solcher Fettsäuren mit gerader Anzahl an Kohlenstoffatomen, z.B. Erucasäure, Laurinsäure, Palmitinsäure und insbesondere C₁₈-Fettsäuren wie Stearinsäure, Ölsäure, Linolsäure oder Linolensäure. Tierische Öle c) sind allgemein bekannt und kommerziell erhältlich. Unter dem Begriff tierische Öle im Sinne der vorliegenden Erfindung werden z.B. Öle tierischen Ursprungs verstanden wie Waltranöl, Lebertranöl, Moschusöl oder Nerzöl. Pflanzenöle c) sind allgemein bekannt und kommerziell erhältlich. Unter dem Begriff Pflanzenöle im Sinne der vorliegenden Erfindung werden z.B. Öle aus ölliefernden Pflanzenarten wie Sojaöl, Rapsöl, Maiskeimöl, Sonnenblumenöl, Baumwollsaatöl, Leinöl, Kokosöl, Palmöl, Distelöl, Walnussöl, Erdnussöl, Olivenöl oder Rhizinusöl, insbesondere Rapsöl verstanden, wobei unter den Pflanzenölen auch deren Umesterungsprodukte verstanden werden, z.B. Alkylester wie Rapsölmethylester oder Rapsölethylester. Die Pflanzenöle sind bevorzugt Ester von C₁₀-C₂₂-, vorzugsweise C₁₂-C₂₀-Fettsäuren. Die C₁₀-C₂₂-Fettsäureester sind beispielsweise Ester ungesättigter oder gesättigter C₁₀-C₂₂-Fettsäuren, insbesondere mit gerader Kohlenstoffatomzahl, z.B. Erucasäure, Laurinsäure, Palmitinsäure und insbesondere C₁₈-Fettsäuren wie Stearinsäure, Ölsäure, Linolsäure oder Linolensäure. Beispiele für Pflanzenöle sind C₁₀-C₂₂-Fettsäure-Ester von Glycerin oder Glykol mit den C₁₀-C₂₂-Fettsäuren, oder C₁-C₂₀-Alkyl-C₁₀-C₂₂-Fettsäure-Ester, wie sie z.B. durch Umesterung der vorgenannten Glycerin- oder Glykol-C₁₀-C₂₂-Fettsäure-Ester mit C₁-C₂₀-Alkoholen (z.B. Methanol, Ethanol, Propanol oder Butanol) erhalten werden können. Die Umesterung kann nach bekannten Methoden erfolgen, wie sie z.B. beschrieben sind im Römpp Chemie Lexikon, 9. Auflage, Band 2, Seite 1343, Thieme Verlag Stuttgart. Die Pflanzenöle können in den erfindungsgemäßen Adjuvantien z.B. in Form kommerziell erhältlicher Pflanzenöle, insbesondere Rapsöle wie Rapsölmethylester, z.B. Phytorob^®B (Novance, Frankreich), Edenor^® MESU und Agnique^®ME-Reihe (Cognis, Deutschland) Radia^®-Reihe (ICI), Prilube^®-Reihe (Petrofina) oder Biodiesel oder in Form kommerziell erhältlicher pflanzenölhaltiger Formulierungszusatzstoffe, insbesondere solcher auf Basis von Rapsölen wie Rapsölmethylester, z.B. Hasten^® (Victorian Chemical Company, Australien, nachfolgend Hasten genannt, Hauptbestandteil: Rapsölethylester), Actirob^®B (Novance, Frankreich, nachfolgend ActirobB genannt, Hauptbestandteil: Rapsölmethylester), Rako-Binol^® (Bayer AG, Deutschland, nachfolgend Rako-Binol genannt, Hauptbestandteil: Rapsöl), Renol^® (Stefes, Deutschland, nachfolgend Renol genannt, Pflanzenölbestandteil: Rapsölmethylester) oder Stefes Mero^® (Stefes, Deutschland, nachfolgend Mero genannt, Hauptbestandteil: Rapsölmethylester) enthalten sein. Beispiele für synthetische Fettsäureester sind z.B. solche die sich von Fettsäuren mit ungerader Kohlenstoffatomanzahl ableiten, wie C₁₁-C₂₁-Fettsäureester.

Suitable organic solvents (component c) are, for example:

• 1) hydrocarbons which may be unsubstituted or substituted, for example 1a) aromatic hydrocarbons, for example - mono- or polyalkyl-substituted benzenes such as toluene, xylenes, mesitylene, ethylbenzene, or - mono- or polyalkyl-substituted naphthalenes such as 1-methylnaphthalene , 2-methylnaphthalene or dimethylnaphthalene, or - other benzene-derived aromatic hydrocarbons, such as indan or Tetralin ^® , or - mixtures thereof, 1b) aliphatic hydrocarbons, for example - linear or branched aliphatics, for example of the general formula C _n H _{2n + 2} , such as pentane, hexane, octane, 2-methylbutane or 2,2,4-trimethylpentane, or - cyclic, optionally alkyl-substituted aliphatics, such as cyclohexane or methylcyclopentane, or - mixtures thereof, such as solvents of the Exxsol ^® D series, Isopar ^® series or Bayo ^® series, for example Bayol ^® 82 (ExxonMobil Chemicals), or the Isane ^® IP series or HydroSeal ^® G series (TotalFinaElf), 1c) mixtures of aromatic and aliphatic hydrocarbons such as solvent of Solvesso ^® series such as Solvesso ^® 100, Solvesso ^® 150 or Solvesso ^® 200 (ExxonMobil Chemicals), of the Solvarex ^® / Solvaro ^® series (TotalFinaElf) or the Caromax ^® series, for example Caromax ^® 28 ( Petrochem Carless), or 1d) halogenated hydrocarbons, such as halogenated aromatic and aliphatic hydrocarbons, such as chlorobenzene or methylene chloride, or
• 2) aprotic, polar solvents, such as ethers, esters of C ₁ -C ₉ -alkanoic acids which may be mono-, di- or polyfunctional, such as their mono-, di- or triesters, for example with C ₁ -C ₁₈ -alkyl alcohols , ketones low Tautomerietendenz, phosphoric ester, amides, nitriles or sulfones, for example diisobutyl adipate, Rhodiasolv ^® RPDE (Rhodia), cyclohexanone, Jeffsol ^® PC (Huntsman), γ-butyrolactone, N-methylpyrrolidone, dimethyl sulfoxide, acetonitrile, Tributylphosphatam or Hostarex ^® PO Series (Clariant), or
• 3) fatty acid ester, for example, of natural origin, for example natural oils such as animal oils or vegetable oils, or synthetic origin, for example Edenor ^® series, for example Edenor ^® MEPa or Edenor ^® MESU or Agnique ^® ME series or Agnique ^® AE series (Cognis), Salim ^® ME series (Salim), Radia ^® series, for example Radia ^® 30167 (ICI), Prilube ^® series, for example Prilube ^® 1530 (Petrofina), Stepan ^® C series (Stepan) or Witconol ^® 23 series (Witco) , The fatty acid esters are preferably esters of C ₁₀ -C ₂₂ -, preferably C ₂ -C ₂₀ fatty acids. The C ₁₀ -C ₂₂ fatty acid esters are, for example, esters of unsaturated or saturated C ₁₀ -C ₂₂ -fatty acids, in particular having an even number of carbon atoms, eg erucic acid, lauric acid, palmitic acid and in particular C ₁₈ -fatty acids such as stearic acid, oleic acid, linoleic acid or linolenic acid. Examples of fatty acid esters such as C ₁₀ -C ₂₂ fatty acid esters are glycerol and glycol esters of fatty acids such as C ₁₀ -C ₂₂ fatty acids or their transesterification products, for example alkyl fatty acid esters such as C ₁ -C ₂₀ -alkyl-C ₁₀ -C ₂₂ -Fatty acid esters, as can be obtained, for example, by transesterification of the aforementioned glycerol or glycol fatty acid esters such as C ₁ -C ₂₂ fatty acid esters with C ₁ -C ₂₀ alcohols (eg, methanol, ethanol, propanol or butanol). The transesterification can be carried out by known methods, as described for example in Rompp Chemie Lexikon, 9th edition, Volume 2, page 1343, Thieme Verlag Stuttgart. Preferred alkyl fatty acid esters such as C ₁ -C ₂₀ -alkyl-C ₁₀ -C ₂₂ -fatty acid esters are methyl esters, ethyl esters, propyl esters, butyl esters, 2-ethylhexyl esters and dodecyl esters. Preferred glycol and glycerol fatty acid ester-such as C ₁₀ -C ₂₂ fatty acid esters are the uniform or mixed Glykolester and Glycerinester of C ₁₀ -C ₂₂ fatty acids, in particular fatty acids having an even number of carbon atoms, for example erucic acid, lauric acid, palmitic acid and in particular C ₁₈ -fatty acids such as stearic acid, oleic acid, linoleic acid or linolenic acid. Animal oils c) are well known and commercially available. For the purposes of the present invention, the term animal oils is understood as meaning, for example, oils of animal origin, such as whale oil, cod liver oil, musk oil or mink oil. Vegetable oils c) are well known and commercially available. For the purposes of the present invention, the term vegetable oils means, for example, oils from oil-supplying plant species such as soybean oil, rapeseed oil, corn oil, sunflower oil, cottonseed oil, linseed oil, coconut oil, palm oil, thistle oil, walnut oil, peanut oil, olive oil or castor oil, in particular rapeseed oil, where among the vegetable oils Their transesterification products are understood, for example, alkyl esters such as rapeseed oil methyl ester or rapeseed oil ethyl ester. The vegetable oils are preferably esters of C ₁₀ -C ₂₂ -, preferably C ₁₂ -C ₂₀ fatty acids. The C ₁₀ -C ₂₂ fatty acid esters are, for example, esters of unsaturated or saturated C ₁₀ -C ₂₂ -fatty acids, in particular having an even number of carbon atoms, eg erucic acid, lauric acid, palmitic acid and in particular C ₁₈ -fatty acids such as stearic acid, oleic acid, linoleic acid or linolenic acid. Examples of vegetable oils are C ₁₀ -C ₂₂ fatty acid esters of glycerol or glycol with the C ₁₀ -C ₂₂ fatty acids, or C ₁ -C ₂₀ alkyl C ₁₀ -C ₂₂ fatty acid esters, as described, for example, by Transesterification of the aforementioned glycerol or glycol C ₁₀ -C ₂₂ fatty acid esters with C ₁ -C ₂₀ alcohols (eg, methanol, ethanol, propanol or butanol) can be obtained. The transesterification can be carried out by known methods, as described for example in Rompp Chemie Lexikon, 9th edition, Volume 2, page 1343, Thieme Verlag Stuttgart. The vegetable oils can in the novel adjuvants for example in the form of commercially available vegetable oils, in particular rapeseed oils, such as Rapsölmethylester such Phytorob ^® B (Novance, France), Edenor ^® MESU and Agnique ^® ME series (Cognis, Germany) Radia ^® series (ICI) , Prilube ^® series (Petrofina), or biodiesel or in the form of commercially available pflanzenölhaltiger formulation additives, in particular those based on rapeseed oils, such as Rapsölmethylester, for example Hasten ^® (Victorian Chemical Company, Australia, hereinbelow termed Hasten, main constituent: rapeseed oil ethyl ester), Actirob ^® B ( Novance, France, hereinafter ActirobB called main ingredient: Rapsölmethylester), Rako-binol ^® (Bayer AG, hereinafter referred to as Rako-binol called Germany, main constituent: rapeseed oil), Renol ^® (Stefes called Renol, Germany, vegetable oil ingredient: Rapsölmethylester) or Stefes Mero ^® (Stefes, Germany, termed Mero called main constituent: rapeseed lmethylester be included). Examples of synthetic fatty acid esters are, for example, those derived from fatty acids of odd carbon number, such as C ₁₁ -C ₂₁ fatty acid esters.

preferred organic solvents are aromatic hydrocarbons, aliphatic hydrocarbons and fatty acid esters like vegetable oils like triglycerides of fatty acids with 10 to 22 carbon atoms, which are both saturated and unsaturated, linear or can be branched and optionally further functional groups, such as corn oil, rapeseed oil, sunflower seed oil, cottonseed oil, linseed oil, soybean oil, coconut oil, palm oil, thistle oil or castor oil, and their Transesterification products such as fatty acid alkyl esters, and mixtures thereof.

The solvent can be contained alone or in a mixture. The solvent used or solvent mixture preferably has a low dissolving power for the used or the phenylsulfonamides used (component a).

Of the Total solvent content in the oil suspension concentrates according to the invention is generally between 5 and 95 wt.%, Preferably in the range between 20 and 80% by weight. The proportion of polar solvents such as aprotic, polar is generally below 20 wt .-%, preferably in the range of 0 to 10% by weight.

The sulfosuccinates (component d) contained in the oil suspension concentrates according to the invention may be, for example, mono- or diesters of sulfosuccinic acid, preferably those of the general formula (III) R ¹ - (X ₁ ) _n -O-CO-CH ₂ -CH (SO ₃ M) -CO-O- (X ₂ ) _m -R ² (III) in which
R ^{1 is} H or an unsubstituted or substituted C ₁ -C ₃₀ -hydrocarbon radical, such as C ₁ -C ₃₀ -alkyl or C ₇ -C ₃₀ -alkylaryl,
R ^{2 is} H or an unsubstituted or substituted C ₁ -C ₃₀ hydrocarbon radical such as C ₁ -C ₃₀ alkyl or C ₇ -C ₃₀ alkylaryl, or is a cation, for example a metal cation such as an alkali or alkaline earth metal cation, or a Ammonium cation such as NH ₄ , alkyl, alkylaryl or poly (arylalkyl) phenylammonium cation,
X ¹ , X ² independently of one another, identically or differently, denote a spacer unit, such as a polyether unit or a polyester unit,
n, m are independently of one another the same or different zero or 1, preferably zero, and
M is a cation, for example a metal cation such as an alkali or alkaline earth metal cation, or an ammonium cation such as NH ₄ , alkyl, alkylaryl or poly (arylalkyl) phenylammonium cation.

Preference is given to sulfosuccinates of the formula (III) in which R ¹ and R ² independently of one another are identical or different, linear or branched or cyclic, saturated or unsaturated C ₁ -C ₂₀ - preferably C ₄ -C ₁₈ -alkyl radicals, such as methyl, ethyl , Butyl, hexyl, cyclohexyl, octyl such as 2-ethylhexyl, decyl, tridecyl or octadecyl radicals, or R ¹ and R ² are C ₇ -C ₂₀ alkylaryl radicals, such as nonylphenyl, 2,4, 6-tri-sec-butylphenyl, 2,4,6-tris (1-phenylethyl) -phenyl, alkylbenzyl or a hydrocime radical, X ₁ and X ₂ are each, independently or differently, polyether units, such as polyethylene glycols - (C ₂ H ₄ O) _p - or polypropylene glycols - (C ₃ H ₆ O) _p - where p = 1 to p = 20, in particular p = 1 to p = 12, or polyester units, such as polyhydroxybutyric acid - (CH [CH ₃ ] -CH ₂ -COO) _q - or polylactic acid - (CH [CH ₃ ] COO) _q - with q = 1 to q = 15, in particular q = 1 to q = 8,
n, m are independently the same or different zero or 1, preferably zero, and M is a cation, eg a metal cation, such as alkali or alkaline earth metal cation, or an ammonium cation, which may be alkyl substituted.

• a1) ein- oder zweifach mit linearen, cyclischen oder verzweigten aliphatischen, cycloaliphatischen und/oder aromatischen Alkoholen verestertes Sulfosuccinat, beispielsweise mit 1 bis 22 C-Atomen im Alkylrest, vorzugsweise ein- oder zweifach mit Methanol, Ethanol, (Iso)propanol, (Iso)butanol, (Iso)pentanol, (Iso)hexanol, Cyclohexanol, (Iso)heptanol, (Iso)octanol (insbesondere: Ethylhexanol), (Iso)nonanol, (Iso)decanol, (Iso)undecanol, (Iso)dodecanol oder (Iso)tridecanol verestertes Mono- oder Dialkalisulfosuccinat, insbesondere Mono- oder Dinatriumsulfosuccinat,
• a2) ein- oder zweifach mit (Poly) Alkylenoxidaddukten von Alkoholen verestertes Sulfosuccinat, beispielsweise mit 1 bis 22 C-Atomen im Alkylrest und 1 bis 200, vorzugsweise 2 bis 200 Alkylenoxideinheiten im (Poly) Alkylenoxidanteil, vorzugsweise ein- oder zweifach mit Dodecyl/Tetradecyl-Alkohol +2-5 mol Ethylenoxid oder mit i-Tridecyl+3mol Ethylenoxid verestertes Mono- oder Dialkalisulfosuccinat, insbesondere Mono- oder Dinatriumsulfosuccinat,
• a3) das Dialkali, vorzugsweise das Dinatriumsalz von einfach mit Aminen oder aminoterminierten (Poly) Alkylenoxidaddukten von Alkoholen, Aminen, Fettsäuren, Estern oder Amiden umgesetztem und nachfolgend sulfoniertem Maleinsäureanhydrid, beispielsweise mit 1 bis 22 C-Atomen im Alkylrest und 1 bis 200, vorzugsweise 2 bis 200 Alkylenoxy-Einheiten im (Poly) Alkylenoxidteil, vorzugsweise das Dinatriumsalz von einfach mit Kokosfettamin umgesetztem und nachfolgend sulfoniertem Maleinsäureanhydrid,
• a4) das Dialkali, vorzugsweise das Dinatriumsalz von einfach mit Amiden oder (Poly) Alkylenoxidaddukten von Amiden umgesetztem und nachfolgend sulfoniertem Maleinsäureanhydrid, beispielsweise mit 1 bis 22 C-Atomen im Alkylrest und 1 bis 200, vorzugsweise 2 bis 200 Alykylenoxy-Einheiten im (Poly) Alkylenoxidteil, vorzugsweise das Dinatriumsalz von einfach mit Oleylamid+2 mol Ethylenoxid umgesetztem und nachfolgend sulfoniertem Maleinsäureanhydrid und/oder
• a5) das Tetraalkali, vorzugsweise das Tetranatriumsalz von N-(1,2-dicarboxyethyl-)-N-Octadecylsulfo-succinamat.

Sulfosuccinates contained according to the invention are, for example

• a1) sulfosuccinate esterified once or twice with linear, cyclic or branched aliphatic, cycloaliphatic and / or aromatic alcohols, for example with 1 to 22 C atoms in the alkyl radical, preferably once or twice with methanol, ethanol, (iso) propanol, ( Iso) butanol, (iso) pentanol, (iso) hexanol, cyclohexanol, (iso) heptanol, (iso) octanol (in particular: ethylhexanol), (iso) nonanol, (iso) decanol, (iso) undecanol, (iso) dodecanol or (iso) tridecanol esterified mono- or di-alkali sulfosuccinate, in particular mono- or disodium sulfosuccinate,
• a2) sulfosuccinate esterified once or twice with (poly) alkylene oxide adducts of alcohols, for example with 1 to 22 C atoms in the alkyl radical and 1 to 200, preferably 2 to 200 alkylene oxide units in the (poly) alkylene oxide moiety, preferably once or twice with dodecyl / Tetradecyl alcohol + 2-5 mol of ethylene oxide or mono- or di-alkali sulfosuccinate esterified with i-tridecyl + 3 mol of ethylene oxide, in particular mono- or disodium sulfosuccinate,
• a3) the dialkali, preferably the disodium salt of simply reacted with amines or amino-terminated (poly) Alkylenoxidaddukten of alcohols, amines, fatty acids, esters or amides and subsequently sulfonated maleic anhydride, for example having 1 to 22 carbon atoms in the alkyl radical and 1 to 200, preferably 2 to 200 alkyleneoxy units in the (poly) alkylene oxide part, preferably the disodium salt of maleic anhydride which has been reacted with coconut fatty amine and subsequently sulfonated,
• a4) the dialkali, preferably the disodium salt of simply reacted with amides or (poly) Alkylenoxidaddukten of amides and subsequently sulfonated maleic anhydride, for example having 1 to 22 carbon atoms in the alkyl radical and 1 to 200, preferably 2 to 200 Alykylenoxy units in (poly ) Alkylenoxidteil, preferably the disodium salt of simply reacted with oleyl amide + 2 moles of ethylene oxide and subsequently sulfonated maleic anhydride and / or
• a5) the tetraalkali, preferably the tetrasodium salt of N- (1,2-dicarboxyethyl) -N-octadecylsulfo-succinamate.

• a1) Natrium-Dialkylsulfosuccinat, z.B. Natrium-Di(C₄-C₁₈)alkylsulfosuccinat wie Natrium-Diisooctylsulfosuccinat, vorzugsweise Natrium-Di(2-ethylhexyl)sulfosuccinat, kommerziell beispielsweise in Form der Aerosol^®-Marken (Cytec), der Agrilan^®- oder Lankropol^®-Marken (Akzo Nobel), der Empimin^®-Marken (Albright&Wilson), der Cropol^®-Marken (Croda), der Lutensit^®-Marken (BASF) der Triton^®-Marken (Union Carbide), der Geropon^®-Marken (Rhodia) oder der Imbirol^®-, Madeol^®- oder Polirol^®-Marken (Cesalpinia) erhältlich,
• a2) Natrium- Alkoholpolyethylenglykolethersulfosuccinat, kommerziell beispielsweise in Form von Geropon^® ACR-Marken (Rhodia) erhältlich,
• a3) Dinatrium-Alkoholpolyethylenglykolethersemisulfosuccinat, kommerziell beispielsweise in Form der Aerosol^®-Marken (Cytec), der Marlinat^®- oder Sermul^®-Marken (Condea), der Empicol^®-Marken (Albright&Wilson), der Secosol^®-Marken (Stepan), der Geropon^®-Marken (Rhodia), der Disponil^®- oder Texapon^®-Marken (Cognis) oder der Rolpon^®-Marken (Cesalpinia) erhältlich,
• a4) Dinatrium-N-Alkylsulfosuccinamat, kommerziell beispielsweise in Form der Aerosol^®-Marken (Cytec), der Rewopol^®- oder Rewoderm^®-Marken (Rewo), der Empimin^®-Marken (Albright&Wilson), der Geropon^®-Marken (Rhodia) oder der Polirol^®-Marken (Cesalpinia) erhältlich,
• a5) Dinatrium-Fettsäureamidpolyethylenglykolethersemisulfosuccinat, kommerziell beispielsweise in Form der Elfanol^®- oder Lankropol^®-Marken (Akzo Nobel), der Rewoderm^®-, Rewocid^®- oder Rewopol^®-Marken (Rewo), der Emcol^®-Marken (Witco), der Standapol^®-Marken (Cognis) oder der Rolpon^®-Marken (Cesalpinia) erhältlich, und
• a6) Tetranatrium-N-(1,2-dicarboxyethyl)-N-Octadecyl-sulfosuccinamat, kommerziell beispielsweise in Form von Aerosol 22^®- (Cytec) erhältlich.

Examples of sulfosuccinates of groups a1) to a5) which are commercially available and preferred in the context of the present invention are listed below:

• a1) sodium dialkylsulfosuccinate, for example sodium di (C ₄ -C ₁₈₎ alkylsulfosuccinate such as sodium diisooctylsulfosuccinate, preferably sodium di (2-ethylhexyl) sulfosuccinate, commercially available for example in the form of aerosol ^® brands (Cytec), the Agrilan® ^® - or Lankropol ^® brands (Akzo Nobel), the Empimin ^® brands (Albright & Wilson), the Cropol ^® brands (Croda), the Lutensit® ^® brands (BASF) of Triton ^® brands (Union Car bide), the Geropon ^® brands (Rhodia) or the Imbirol ^® -, Madeol ^® - or Polirol® ^® brands (Cesalpinia),
• a2) sodium Alkoholpolyethylenglykolethersulfosuccinat commercially available, for example in the form of Geropon ^® ACR brands (Rhodia),
• a3) disodium Alkoholpolyethylenglykolethersemisulfosuccinat, commercially available for example in the form of aerosol ^® brands (Cytec), the Marlinat ^® - or Sermul ^® brands (Condea), the Empicol ^® brands (Albright & Wilson), the Secosol ^® brands (Stepan), the Geropon ^® brands (Rhodia), the Disponil ^® - or Texapon ^® brands (Cognis) or the Rolpon available ^® brands (Cesalpinia),
• a4) disodium N-alkylsulfosuccinamate, commercially available for example in the form of aerosol ^® brands (Cytec), the Rewopol ^® - ^® or Rewoderm ^® brands (Rewo), the Empimin ^® brands (Albright & Wilson), the Geropon brands (Rhodia ) or Polirol® available ^® brands (Cesalpinia),
• a5) disodium Fettsäureamidpolyethylenglykolethersemisulfosuccinat, commercially available for example in the form of Elfanol ^® - or Lankropol ^® brands (Akzo Nobel), the Rewoderm ^® -, Rewocid ^® - or Rewopol ^® brands (Rewo), the Emcol ^® brands (Witco), of Standapol ^® brands (Cognis) or the Rolpon ^® brands (Cesalpinia), and
• a6) Tetrasodium N- (1,2-dicarboxyethyl) -N-octadecylsulfosuccinamate, commercially available, for example, in the form of Aerosol ^22® (Cytec).

Sulfosuccinates are commercially available, for example, as an aerosol ^® - (Cytec), Agrilan® ^® - or Lankropol ^® - (Akzo Nobel), Empimin ^® - (Huntsman), Cropol ^® - (Croda), Lutensit ^® - (BASF), Triton ^® GR series (Union Carbide), Imbirol ^® - / Madeol ^® - / Polirol® ^® - (Cesalpinia); Geropon ^® AR-series or Geropon SDS ^® (Rhodia) available.

preferred Sulfosuccinates are e.g. the sodium, potassium and ammonium salts of bis (alkyl) sulfosuccinates, wherein the alkyl radicals are the same or contain from 4 to 16 carbon atoms, and preferably butyl, Hexyl, octyl, such as 2-ethylhexyl or Decyl radicals are those which may be linear or branched.

Of the Total amount of sulfosuccinate or sulfosuccinates in the oil suspension concentrates according to the invention is generally between 0.1 and 60 wt.%, In particular in Range between 0.5 and 30 wt.%.

As usual auxiliary and additives (component f) can be used in the oil suspension concentrates according to the invention e.g. still to be included: surfactants such as emulsifiers and dispersants, Thickening and thixotropic agents, wetting, anti-drift, adhesive, Penetrating, preservative and antifreeze, antioxidants, Solubilizers, filling, Carrier- and dyes, defoamers, Fertilizer, Evaporation inhibitor, as well as affecting the pH and the viscosity Medium.

• 1) polyalkoxylierte, vorzugsweise polyethoxylierte, gesättigte und ungesättigte aliphatische Alkohole, – mit 8 bis 24 C-Atomen im Alkylrest, der sich von den entsprechenden Fettsäuren oder aus petrochemischen Produkten ableitet, und – mit 1 bis 100, vorzugsweise 2 bis 50, Ethylenoxideinheiten (EO), wobei die freie Hydroxy-Gruppe gegebenenfalls alkoxyliert ist, – die z. B. kommerziell als Genapol^®X- und Genapol^®O-Reihe (Clariant), Crovol^®M-Reihe (Croda) oder Lutensol^®Reihe (BASF) erhältlich sind,
• 2) polyalkoxylierte, vorzugsweise polyethoxylierte Arylalkylphenole, wie z. B. 2,4,6-Tris-(1-phenylethyl)-phenol (Tristyrylphenol) mit einem mittleren Ethoxylierungsgrad zwischen 10 und 80, bevorzugt 16 bis 40, wie z. B. Soprophor^®BSU (Rhodia) oder HOE S 3474 (Clariant),
• 3) polyalkoxylierte, vorzugsweise polyethoxylierte Alkylphenole mit einem oder mehreren Alkylresten, wie z. B. Nonylphenol oder Tri-sec-butylphenol, und einem Ethoxylierungsgrad zwischen 2 und 40, bevorzugt 4 bis 15, wie z. B. Arkopal^®N-Reihe oder Sapogenat^®T-Reihe (Clariant),
• 4) polyalkoxylierte, vorzugsweise polyethoxylierte Hydroxyfettsäuren oder Hydroxyfettsäuren enthaltene Glyceride, wie z. B. Ricinin bzw. Rizinusöl, mit einem Ethoxylierungsgrad zwischen 10 und 80, bevorzugt 25 bis 40, wie z. B. Emulsogen^®EL-Reihe (Clariant) oder Agnique^®CSO-Reihe (Cognis),
• 5) polyalkoxylierte, vorzugsweise polyethoxylierte Sorbitanester, wie z. B. Atplus^®309 F (Uniqema) oder Alkamuls^®-Reihe (Rhodia)
• 6) Di- und Tri-block-copolymere, z.B. aus Alkylenoxiden, z.B. aus Ethylen- und Propylenoxid mit mittleren Molmassen zwischen 200 und 10000, vorzugsweise 1000 bis 4000 g/mol, wobei der Massenanteil des polyethoxylierte Blocks zwischen 10 und 80% variiert, wie z. B. Genapol^®PF-Reihe (Clariant), Pluronic^®-Reihe (BASF), oder Synperonic^®PE-Reihe (Unigema),

Suitable emulsifiers and dispersants are, for example, nonionic emulsifiers and dispersants, for example:

• 1) polyalkoxylated, preferably polyethoxylated, saturated and unsaturated aliphatic alcohols, - having 8 to 24 carbon atoms in the alkyl radical, which is derived from the corresponding fatty acids or from petrochemical products, and - with 1 to 100, preferably 2 to 50, ethylene oxide units ( EO), wherein the free hydroxy group is optionally alkoxylated, - z. B. O series (Clariant), Crovol ^® M series (Croda) or Lutensol ^® are commercially available as Genapol X and Genapol ^{® ®} series (BASF),
• 2) polyalkoxylated, preferably polyethoxylated arylalkylphenols, such as. B. 2,4,6-tris (1-phenylethyl) phenol (tristyrylphenol) having a mean degree of ethoxylation between 10 and 80, preferably 16 to 40, such as. B. Soprophor ^® BSU (Rhodia) or HOE S 3474 (Clariant),
• 3) polyalkoxylated, preferably polyethoxylated alkylphenols having one or more alkyl radicals, such as. As nonylphenol or tri-sec-butylphenol, and a degree of ethoxylation between 2 and 40, preferably 4 to 15, such as. B. Arkopal N ^® series or Sapogenat T ^® series (Clariant),
• 4) polyalkoxylated, preferably polyethoxylated hydroxyfatty acids or hydroxyfatty acids contained glycerides, such as. As ricinine or castor oil, with a degree of ethoxylation between 10 and 80, preferably 25 to 40, such as. B. Emulsogen ^® EL series (Clariant) or Agnique ^® CSO series (Cognis),
• 5) polyalkoxylated, preferably polyethoxylated sorbitan esters, such as. B. Atplus 309 ^® F (Uniqema) or Alkamuls ^® series (Rhodia)
• 6) di- and tri-block copolymers, for example of alkylene oxides, for example of ethylene oxide and propylene oxide having average molecular weights between 200 and 10,000, preferably 1000 to 4000 g / mol, the mass fraction of the polyethoxylated block varying between 10 and 80%, such as B. Genapol ^® PF series (Clariant), Pluronic ^® series (BASF) or Synperonic ^® PE series (Uniqema)

preferred Nonionic emulsifiers and dispersants are e.g. polyethoxylated Alcohols, polyethoxylated triglycerides containing hydroxy fatty acids and polyethylene oxide-polypropylene oxide block copolymers.

Of the Total content of nonionic emulsifiers and dispersants in the oil suspension concentrates according to the invention is generally between 0 and 20 wt.%. Become nonionic Emulsifiers and dispersants, in addition to their emulsifying / dispersing Properties, also to increase the biological effectiveness, z. B. as a penetration or adhesive used, you can Proportion in the oil suspension concentrates according to the invention increase up to 60% by weight.

• 1) polyalkoxylierte, vorzugsweise polyethoxylierte Emulgatoren/Dispergatoren (vgl. Komponente e), die ionisch modifiziert sind, z. B. durch Umsetzung der endständigen freien Hydroxylfunktion des Polyethylenoxidblocks zu einem Sulfat- oder Phosphatester (z. B. als Alkali- und Erdalkalimetallsalze), wie z. B. Genapol^®LRO oder Dispergiermittel 3618 (Clariant), Emulphor^® (BASF) oder Crafol^®AP (Cognis),
• 2) Alkali- und Erdalkalimetallsalze von Alkylarylsulfonsäuren mit linearer oder verzweigter Alkylkette, wie Phenylsulfonat CA oder Phenylsulfonat CAL (Clariant), Atlox^® 3377BM (ICI), Empiphos^®TM-Reihe (Huntsman)
• 3) Polyelektrolyte, wie Ligninsulfonate, Kondensationsprodukte aus Naphthalinsulfonat und Formaldehyd, Polystyrolsulfonat oder sulfonierte ungesättigte oder aromatische Polymere (Polystyrole, Polybutadiene oder Polyterpene), wie Tamol^®-Reihe (BASF), Morwet^®D425 (Witco), Kraftsperse^®-Reihe (Westvaco), Borresperse^®-Reihe (Borregard).

There are also ionic emulsifiers and dispersants in question, for example:

• 1) polyalkoxylated, preferably polyethoxylated emulsifiers / dispersants (see component e), which are ionically modified, for. Example by reacting the terminal free hydroxyl function of the polyethylene oxide block to a sulfate or phosphate ester (eg., As alkali and alkaline earth metal salts), such. B. Genapol ^® LRO or dispersant 3618 (Clariant), Emulphor ^® (BASF) or Crafol ^® AP (Cognis),
• 2) alkali metal and alkaline earth metal salts of alkylarylsulfonic acids having a linear or branched alkyl chain, such as phenylsulfonate CA or phenylsulfonate CAL (Clariant), Atlox ^® 3377BM (ICI), Empiphos ^® TM series (Huntsman)
• 3) polyelectrolytes, such as lignosulfonates, condensates of naphthalenesulfonate and formaldehyde, polystyrenesulfonate or sulfonated unsaturated or aromatic polymers (polystyrenes, polybutadienes or polyterpenes), such as Tamol ^® series (BASF), Morwet ^® D425 (Witco), Kraftsperse ^® series (Westvaco ), Borresperse ^® series (Borregard).

preferred ionic emulsifiers / dispersants are e.g. Salts of alkylarylsulfonic acids and Polyelectrolytes from the polycondensation of naphthalenesulfonate and formaldehyde.

Of the Total content of ionic emulsifiers and dispersants in the oil suspension concentrates according to the invention is generally between 0 and 20 wt.%, In particular between 0 and 8% by weight.

• 1) modifizierte natürliche Silikate, wie chemisch modifizierte Bentonite, Hectorite, Attapulgite, Montmorillonite, Smektite oder andere Silikatmineralien, wie Bentone^® (Elementis), Attagel^® (Engelhard), Agsorb^® (Oil-Dri Corporation) oder Hectorite^® (Akzo Nobel)
• 2) synthetische Silikate, wie Silikate der Sipernat^®-, Aerosil^®- oder Durosil^®-Reihe (Degussa), der CAB-O-SIL^®-Reihe (Cabot) oder der Van Gel-Reihe (R.T. Vanderbilt),
• 3) Verdicker auf Basis synthetischer Polymere, wie Verdicker der Thixin^®- oder Thixatrol^®-Reihe (Elementis).
• 4) Verdicker auf Basis natürlicher Polymere und natürlicher Öle, z.B. aus der Thixin^®- oder Thixatrol^®-Reihe (Elementis).

Suitable thickening and thixotropic agents are, for example:

• 1) modified natural silicates, such as chemically modified bentonites, hectorites, attapulgites, montmorillonites, smectites or other silicate minerals, such as Bentone ^® (Elementis), Attagel ^® (Engelhard), Agsorb ^® (Oil-Dri Corporation) or Hectorite ^® (Akzo Nobel)
• 2) synthetic silicates such as silicates of the Sipernat ^® -, Aerosil ^® - or Durosil ^® series (Degussa), the CAB-O-SIL ^® series (Cabot) or the Van Gel series (RT Vanderbilt)
• 3) thickeners based on synthetic polymers, such as thickeners of Thixin® ^® - or Thixatrol ^® series (Elementis).
• 4) thickeners based on natural polymers and natural oils, for example from Thixin® ^® - or Thixatrol ^® series (Elementis).

preferred Thickening and thixotropic agents are e.g. modified phyllosilicates and thickeners based on synthetic polymers.

Of the Proportion of thickening and thixotropic agents in the oil suspension concentrates according to the invention is generally between 0 and 5 wt.%, In particular between 0.2 and 3 wt.%.

• a) 0,1 bis 30 Gew.-% eines oder mehrere herbizider Wirkstoffe aus der Gruppe der Sulfonamide,
• b) 2 bis 40 Gew.-% eines oder mehrere Safener,
• c) 20 bis 80 Gew.-% eines oder mehrere Lösungsmittel,
• d) 0,5 bis 30 Gew.-% eines oder mehrere Sulfosuccinate,
• e) 3 bis 20 Gew.-% eines oder mehrere von a) und b) verschiedener agrochemischer Wirkstoffe,
• f) 0 bis 20 Gew.-% eines oder mehrere nichtionischer Emulgatoren und Dispergatoren, 0 bis 8 Gew.-% eines oder mehrerer ionischer Emulgatoren und Dispergatoren 0 bis 3 Gew.-% eines oder mehrerer Verdickungs- und Thixotriopiermittel.

Preference is given to oil suspension concentrates according to the invention comprising:

• a) 0.1 to 30% by weight of one or more herbicidally active substances from the group of the sulfonamides,
• b) from 2 to 40% by weight of one or more safeners,
• c) from 20 to 80% by weight of one or more solvents,
• d) from 0.5 to 30% by weight of one or more sulfosuccinates,
• e) from 3 to 20% by weight of one or more of a) and b) of various agrochemical active substances,
• f) 0 to 20 wt .-% of one or more nonionic emulsifiers and dispersants, 0 to 8 wt .-% of one or more ionic emulsifiers and dispersants 0 to 3 wt .-% of one or more thickening and Thixotriopiermittel.

• a) ein oder mehrere herbizide Wirkstoffe der Formel (I) oder Formel (IV) und/oder deren Salze, vorzugsweise A1.1 bis A19.2,
• b) einen Safener aus der Gruppe S1-1, S1-9 und S2-1,
• c) ein organisches Lösungsmittel aus der Gruppe der aliphatischen Kohlenwasserstoffe, der Gemische von aromatischen und aliphatischen Kohlenwasserstoffe und der Pflanzenöle wie Rapsölmethylester, und
• d) ein Alkali Di(C₄-C₁₈)alkylsulfosuccinat wie Natrium Di(C₄-C₁₈)alkylsulfosuccinat.

In a preferred embodiment, the inventive oil suspension concentrate

• a) one or more herbicidal active compounds of the formula (I) or formula (IV) and / or salts thereof, preferably A1.1 to A19.2,
• b) a safener from the group S1-1, S1-9 and S2-1,
• c) an organic solvent from the group of aliphatic hydrocarbons, mixtures of aromatic and aliphatic hydrocarbons and vegetable oils such as rapeseed oil methyl ester, and
• d) an alkali di (C ₄ -C ₁₈ ) alkyl sulfosuccinate such as sodium di (C ₄ -C ₁₈ ) alkyl sulfosuccinate.

As particularly preferred examples, oil suspension concentrates according to the invention may be mentioned, which contain the following components without this being intended to limit them. Here, Solvesso is a solvent from the Solvesso ^® series, preferably Solvesso ^® 200, Bayol is a solvent from the Bayol ^® series, Bayol ^® 82, Edenor = Edenor ^® MESU and Actirob = Actirob preferably ^® B.

Sodium di (2-ethylhexyl) sulfosuccinate + Solvesso + S1-1 + A1.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A1.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A1.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + Al.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-1 + A2.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A2.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A2.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A2.1, sodium di (2-ethylhexyl) sulfosuccinate + Solvesso + S1-1 + A3.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A3.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A3.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A3.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-1 + A4.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A4.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A4.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A4.1, sodium di (2-ethylhexyl) sulfosuccinate + Solvesso + S1-1 + A5.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A5.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A5.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A5.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-1 + A6.1 + EX, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A6.1 + EX, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A6.1 + EX, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A6.1 + EX, sodium di (2-ethylhexyl) sulfosuccinate + Solvesso + S1-1 + A6.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A6.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A6.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A6.1, sodium di (2-ethylhexyl) sulfosuccinate + Solvesso + S1-1 + A7.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A7.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A7.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A7.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-1 + A8.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A8.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A8.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A8.1, sodium di (2-ethylhexyl) sulfosuccinate + Solvesso + S1-1 + A9.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A9.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A9.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A9.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-1 + A10.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A10.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A10.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A10.1, sodium di (2-ethylhexyl) sulfosuccinate + Solvesso + S1-1 + A11.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A11.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A11.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A11.1, sodium di (2-ethylhexyl) sulfosuccinate + Solvesso + S1-1 + A12.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A12.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A12.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A12.1, sodium di (2-ethylhexyl) sulfosuccinate + Solvesso + S1-1 + A13.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A13.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A13.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A13.1, sodium di (2-ethylhexyl) sulfosuccinate + Solvesso + S1-1 + A14.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A14.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A14.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A14.1, sodium di (2-ethylhexyl) sulfosuccinate + Solvesso + S1-1 + A15.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A15.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A15.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A15.1, sodium di (2-ethylhexyl) sulfosuccinate + Solvesso + S1-1 + A16.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A16.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A16.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A16.1, sodium di (2-ethylhexyl) sulfosuccinate + Solvesso + S1-1 + A17.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A17.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A17.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A17.1, sodium di (2-ethylhexyl) sulfosuccinate + Solvesso + S1-1 + A18.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A18.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A18.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A18.1, sodium di (2-ethylhexyl) sulfosuccinate + Solvesso + S1-1 + A19.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A19.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A19.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A19.1.

Sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-1 + A1.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A1.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A1.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A1. 2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-1 + A2.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A2.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A2.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A2.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-1 + A3 .2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A3.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A3.2, sodium di (2-ethylhexyl ) sulfosuccinate + Actirob B + S1-1 + A3.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-1 + A4.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A4.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A4.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A4.2, sodium di (2 ethylhexyl) sulfosuccinate + solvesso + S1-1 + A5.2, sodium di (2-ethylhexyl) sulfos uccinate + Bayol + S1-1 + A5.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A5.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A5 .2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-1 + A6.2 + EX, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A6.2 + EX, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A6.2 + EX, Sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A6.2 + EX, Sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-1 + A6.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A6.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A6. 2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A6.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-1 + A7.2, sodium di (2-ethylhexyl ) sulfosuccinate + Bayol + S1-1 + A7.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A7.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A7.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-1 + A8.2, N atrium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A8.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A8.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A8.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-1 + A9.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A9.2 Sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A9.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A9.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-1 + A10.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A10.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A10. 2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A10.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-1 + A11.2, sodium di (2-ethylhexyl ) sulfosuccinate + Bayol + S1-1 + A11.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A11.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A11.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-1 + A12.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A12.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A12.2, sodium -di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A12.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-1 + A13.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A13.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A13.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A13.2 Sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-1 + A14.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A14.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A14.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A14.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-1 + A15. 2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A15.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A15.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A15.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-1 + A16.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A16.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A16. 2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A16.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-1 + A17.2, sodium di (2-ethylhexyl ) sulfosuccinate + Bayol + S1-1 + A17.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A17.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A17.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-1 + A18.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A18.2, sodium di (2-) ethylhexyl) sulfosuccinate + Edenor + S1-1 + A18.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A18.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-1 + A19.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-1 + A19.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-1 + A19.2, sodium di (2 ethylhexyl) sulfosuccinate + Actirob B + S1-1 + A19.2.

Sodium di (2-ethylhexyl) sulfosuccinate + Solvesso + S1-9 + Al.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + Al.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A1.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A1.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-9 + A2.1 Sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A2.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A2.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A2.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-9 + A3.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A3. 1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A3.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A3.1, sodium di (2-ethylhexyl ) sulfosuccinate + solvesso + S1-9 + A4.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A4.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A4 .1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A4.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-9 + A5.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A5.1, sodium di (2 ethylhexyl) sulfosuccinate + Edenor + S1-9 + A5.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A5.1, Natri um-di (2-ethylhexyl) sulfosuccinate + solvesso + S1-9 + A6.1 + EX, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A6.1 + EX, sodium di (2-) ethylhexyl) sulfosuccinate + Edenor + S1-9 + A6.1 + EX, Sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A6.1 + EX, Sodium di (2-ethylhexyl) sulfosuccinate + Solvesso + S1-9 + A6.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A6.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A6.1, sodium -di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A6.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-9 + A7.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A7.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A7.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A7.1 Sodium di (2-ethylhexyl) sulfosuccinate + Solvesso + S1-9 + A8.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A8.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A8.1, sodium di (2-ethylhexyl) sulfosuccinate + A Preparation B + S1-9 + A8.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-9 + A9.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A9.1 Sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A9.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A9.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-9 + A10.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A10.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A10. 1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A10.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-9 + A11.1, sodium di (2-ethylhexyl ) sulfosuccinate + Bayol + S1-9 + A11.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A11.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A11.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-9 + A12.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A12.1, sodium di (2-) ethylhexyl) sulfosuccinate + Edenor + S1-9 + A12.1, sodium di (2-ethylhexy l) sulfosuccinate + Actirob B + S1-9 + A12.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-9 + A13.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A13.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A13.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A13.1, sodium di ( 2-ethylhexyl) sulfosuccinate + solvesso + S1-9 + A14.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A14.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1- 9 + A14.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A14.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-9 + A15.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A15.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A15.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A15.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-9 + A16.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A16.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A16. 1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A16.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-9 + A17.1, sodium di (2-ethylhexyl ) sulfosuccinate + Bayol + S1-9 + A17.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A17.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A17.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-9 + A18.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A18.1, sodium di (2-) ethylhexyl) sulfosuccinate + Edenor + S1-9 + A18.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A18.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-9 + A19.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A19.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A19.1, sodium di (2 ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A19.1.

Sodium di (2-ethylhexyl) sulfosuccinate + Solvesso + S1-9 + A1.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A1.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A1.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A1.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-9 + A2.2 Sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A2.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A2.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A2.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-9 + A3.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A3. 2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A3.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A3.2, sodium di (2-ethylhexyl ) sulfosuccinate + solvesso + S1-9 + A4.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A4.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A4 .2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A4.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-9 + A5.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A5.2, sodium di (2 ethylhexyl) sulfosuccinate + Edenor + S1-9 + A5.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A5.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1- 9 + A6.2 + EX, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A6.2 + EX, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A6.2 + EX, Sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A6.2 + EX, Sodium di (2-ethylhexyl) sulfosuccinate + Solvesso + S1-9 + A6.2, sodium di (2 ethylhexyl) sulfosuccinate + Bayol + S1-9 + A6.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A6.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1- 9 + A6.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-9 + A7.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A7.2, sodium di ( 2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A7.2, sodium di (2-ethylhexyl) sulf osuccinate + Actirob B + S1-9 + A7.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-9 + A8.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A8 .2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A8.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A8.2, sodium di (2- ethylhexyl) sulfosuccinate + solvesso + S1-9 + A9.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A9.2, sodium di (2-ethylhexyl) sulfosuc cinate + Edenor + S1-9 + A9.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A9.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-9 + A10 .2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A10.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A10.2, sodium di (2-ethylhexyl ) sulfosuccinate + Actirob B + S1-9 + A10.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-9 + A11.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A11.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A11.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A11.2, sodium di (2 ethylhexyl) sulfosuccinate + solvesso + S1-9 + A12.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A12.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A12.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A12.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-9 + A13.2, sodium di ( 2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A13.2, sodium d i (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A13.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A13.2, sodium di (2-ethylhexyl) sulfosuccinate + Solvesso + S1-9 + A14.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A14.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A14.2, sodium -di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A14.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-9 + A15.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A15.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A15.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A15.2 Sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-9 + A16.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A16.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A16.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A16.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-9 + A17. 2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A17.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A17.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A17.2, sodium -di (2-ethylhexyl) sulfosuccinate + solvesso + S1-9 + A18.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A18.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A18.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A18.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S1-9 + A19.2, Sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S1-9 + A19.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S1-9 + A19.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S1-9 + A19.2.

Sodium di- (2-ethylhexyl) sulfosuccinate + solvesso + S2-1 + A1.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A1.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A1.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A1.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S2-1 + A2.1 Sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A2.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A2.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A2.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S2-1 + A3.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A3. 1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A3.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A3.1, sodium di (2-ethylhexyl ) sulfosuccinate + solvesso + S2-1 + A4.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A4.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A4 .1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A4.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S2-1 + A5.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A5.1, sodium di (2 ethylhexyl) sulfosuccinate + Edenor + S2-1 + A5.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A5.1, sodium di (2-ethylhexyl) sulfosuccinate + Solvesso + S2- 1 + A6.1 + EX, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A6.1 + EX, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A6.1 + EX, Sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A6.1 + EX, Sodium di (2-ethylhexyl) sulfosuccinate + Solvesso + S2-1 + A6.1, sodium di (2 ethylhexyl) sulfosuccinate + Bayol + S2-1 + A6.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A6.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2- 1 + A6.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S2-1 + A7.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A7.1, sodium di ( 2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A7.1, sodium di (2-ethylhexyl) sulf osuccinate + Actirob B + S2-1 + A7.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S2-1 + A8.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A8 .1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A8.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A8.1, sodium di (2-) ethylhexyl) sulfosuccinate + solvesso + S2-1 + A9.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A9.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A9.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A9.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S2-1 + A10.1, sodium di (2 ethylhexyl) sulfosuccinate + Bayol + S2-1 + A10.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A10.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2- 1 + A10.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S2-1 + A11.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A11.1, sodium di ( 2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A11.1, sodium di (2- ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A11.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S2-1 + A12.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A12.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A12.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A12.1, sodium di ( 2-ethylhexyl) sulfosuccinate + solvesso + S2-1 + A13.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A13.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2- 1 + A13.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A13.1, sodium di (2-ethylhexyl) sulfosuccinate + Solvesso + S2-1 + A14.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A14.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A14.1, sodium -di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A14.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S2-1 + A15.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A15.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A15.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A15.1 Sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S2-1 + A16.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A16.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A16.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A16.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S2-1 + A17. 1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A17.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A17.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A17.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S2-1 + A18.1, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A18.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A18. 1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A18.1, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S2-1 + A19.1, sodium di (2-ethylhexyl ) sulfosuccinate + Bayol + S2-1 + A19.1, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A19.1, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A19.1.

Sodium di (2-ethylhexyl) sulfosuccinate + Solvesso + S2-1 + A1.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A1.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A1.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A1.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S2-1 + A2.2 Sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A2.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A2.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A2.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S2-1 + A3.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A3. 2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A3.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A3.2, sodium di (2-ethylhexyl ) sulfosuccinate + solvesso + S2-1 + A4.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A4.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A4 .2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A4.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S2-1 + A5.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A5.2, sodium di (2 ethylhexyl) sulfosuccinate + Edenor + S2-1 + A5.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A5.2, sodium di (2-ethylhexyl) sulfosuccinate + Solvesso + S2- 1 + A6.2 + EX, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A6.2 + EX, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A6.2 + EX, Sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A6.2 + EX, Sodium di (2-ethylhexyl) sulfosuccinate + Solvesso + S2-1 + A6.2, sodium di (2 ethylhexyl) sulfosuccinate + Bayol + S2-1 + A6.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A6.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2- 1 + A6.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S2-1 + A7.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A7.2, sodium di ( 2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A7.2, sodium di (2-ethylhexyl) sulf osuccinate + Actirob B + S2-1 + A7.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S2-1 + A8.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A8 .2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A8.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A8.2, sodium di (2-) ethylhexyl) sulfosuccinate + solvesso + S2-1 + A9.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A9.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A9.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A9.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S2-1 + A10.2, sodium di (2 ethylhexyl) sulfosuccinate + Bayol + S2-1 + A10.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A10.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2- 1 + A10.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S2-1 + A11.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A11.2, sodium di ( 2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A11.2, sodium di (2- ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A11.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S2-1 + A12.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A12.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A12.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A12.2, sodium di ( 2-ethylhexyl) sulfosuccinate + solvesso + S2-1 + A13.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A13.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2- 1 + A13.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A13.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S2-1 + A14.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A14.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A14.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A14.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S2-1 + A15.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A15.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2 -1 + A15.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A15.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S2-1 + A16.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A16.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A16.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A16.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S2-1 + A17.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A17.2, sodium -di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A17.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A17.2, sodium di (2-ethylhexyl) sulfosuccinate + Solvesso + S2-1 + A18.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A18.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A18.2, Natri um-di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A18.2, sodium di (2-ethylhexyl) sulfosuccinate + solvesso + S2-1 + A19.2, sodium di (2-ethylhexyl) sulfosuccinate + Bayol + S2-1 + A19.2, sodium di (2-ethylhexyl) sulfosuccinate + Edenor + S2-1 + A19.2, sodium di (2-ethylhexyl) sulfosuccinate + Actirob B + S2-1 + A19. second

In the above combinations can also several sulfonamides as component a) combined become.

Examples of such combinations are (A1.1) + (A1.2), (A1.1) + (A2.1), (A1.1) + (A2.2), (A1.1) + (A3.1 ), (A1.1) + (A3.2), (A1.1) + (A4.1), (A1.1) + (A4.2), (A1.1) + (A5.1), (A1.1) + (A5.2), (A1.1) + (A6.1), (A1.1) + (A6.2), (A1.1) + (A7.1), (A1 .1) + (A7.2), (A1.1) + (A8.1), (A1.1) + (A8.2), (A1.1) + (A9.1), (A1.1 ) + (A9.2), (A1.1) + (A10.1), (A1.1) + (A10.2), (A1.1) + (A11.1), (A1.1) + (A11.2), (A1.1) + (A12.1), (A1.1) + (A12.2), (A1.1) + (A13.1), (A1.1) + (A13 .2), (A1.1) + (A14.1), (A1.1) + (A14.2), (A1.1) + (A15.1), (A1.1) + (A15.2 ), (A1.1) + (A16.1), (A1.1) + (A16.2), (A1.1) + (A17.1), (A1.1) + (A17.2), (A1.1) + (A18.1), (A1.1) + (A18.2), (A1.1) + (A19.1), (A1.1) + (A19.2),
(A1.2) + (A2.1), (A1.2) + (A2.2), (A1.2) + (A3.1), (A1.2) + (A3.2), (A1 .2) + (A4.1), (A1.2) + (A4.2), (A1.2) + (A5.1), (A1.2) + (A5.2), (A1.2 ) + (A6.1), (A1.2) + (A6.2), (A1.2) + (A7.1), (A1.2) + (A7.2), (A1.2) + (A8.1), (A1.2) + (A8.2), (A1.2) + (A9.1), (A1.2) + (A9.2), (A1.2) + (A10 .1), (A1.2) + (A10.2), (A1.2) + (A11.2), (A1.2) + (A11.2), (A1.2) + (A12.1 ), (A1.2) + (A12.2), (A1.2) + (A13.1), (A1.2) + (A13.2), (A1.2) + (A14.1), (A1.2) + (A14.2), (A1.2) + (A15.1), (A1.2) + (A15.2), (A1.2) + (A16.1), (A1 .2) + (A16.2), (A1.2) + (A17.1), (A1.2) + (A17.2), (A1.2) + (A18.1), (A1.2 ) + (A18.2), (A1.2) + (A19.1), (A1.2) + (A19.2),
(A2.1) + (A2.2), (A2.1) + (A3.1), (A2.1) + (A3.2), (A2.1) + (A4.1), (A2 .1) + (A4.2), (A2.1) + (A5.1), (A2.1) + (A5.2), (A2.1) + (A6.1), (A2.1 ) + (A6.2), (A2.1) + (A7.1), (A2.1) + (A7.2), (A2.1) + (A8.1), (A2.1) + (A8.2), (A2.1) + (A9.1), (A2.1) + (A9.2), (A2.1) + (A10.1), (A2.1) + (A10 .2), (A2.1) + (A12.1), (A2.1) + (A11.2), (A2.1) + (A12.1), (A2.1) + (A12.2 ), (A2.1) + (A13.1), (A2.1) + (A13.2), (A2.1) + (A14.1), (A2.1) + (A14.2), (A2.1) + (A15.1), (A2.1) + (A15.2), (A2.1) + (A16.1), (A2.1) + (A16.2), (A2 .1) + (A17.1), (A2.1) + (A17.2), (A2.1) + (A18.1), (A2.1) + (A18.2), (A2.1 ) + (A19.1), (A2.1) + (A19.2),
(A2.2) + (A3.1), (A2.2) + (A3.2), (A2.2) + (A4.1), (A2.2) + (A4.2), (A2 .2) + (A5.1), (A2.2) + (A5.2), (A2.2) + (A6.1), (A2.2) + (A6.2), (A2.2 ) + (A7.1), (A2.2) + (A7.2), (A2.2) + (A8.1), (A2.2) + (A8.2), (A2.2) + (A9.1), (A2.2) + (A9.2), (A2.2) + (A10.1), (A2.2) + (A10.2), (A2.2) + (A12 .2), (A2.2) + (A11.2), (A2.2) + (A12.2), (A2.2) + (A12.2), (A2.2) + (A13.1 ), (A2.2) + (A13.2), (A2.2) + (A14.1), (A2.2) + (A14.2), (A2.2) + (A15.1), (A2.2) + (A15.2), (A2.2) + (A16.1), (A2.2) + (A16.2), (A2.2) + (A17.1), (A2 .2) + (A17.2), (A2.2) + (A18.1), (A2.2) + (A18.2), (A2.2) + (A19.1), (A2.2 ) + (A19.2),
(A3.1) + (A3.2), (A3.1) + (A4.1), (A3.1) + (A4.2), (A3.1) + (A5.1), (A3 .1) + (A5.2), (A3.1) + (A6.1), (A3.1) + (A6.2), (A3.1) + (A7.1), (A3.1 ) + (A7.2), (A3.1) + (A8.1), (A3.1) + (A8.2), (A3.1) + (A9.1), (A3.1) + (A9.2), (A3.1) + (A10.1), (A3.1) + (A10.2), (A3.1) + (A11.1), (A3.1) + (A11 .2), (A3.1) + (A12.1), (A3.1) + (A12.2), (A3.1) + (A13.1), (A2.2) + (A13.2 ), (A3.1) + (A14.1), (A2.2) + (A14.2), (A3.1) + (A15.1), (A3.1) + (A15.2), (A3.1) + (A16.1), (A3.1) + (A16.2), (A3.1) + (A17.1), (A3.1) + (A17.2), (A3 .1) + (A18.1), (A3.1) + (A18.2), (A3.1) + (A19.1), (A3.1) + (A19.2),
(A3.2) + (A4.1), (A3.2) + (A4.2), (A3.2) + (A5.1), (A3.2) + (A5.2), (A3 .2) + (A6.1), (A3.2) + (A6.2), (A3.2) + (A7.1), (A3.2) + (A7.2), (A3.2 ) + (A8.1), (A3.2) + (A8.2), (A3.2) + (A9.1), (A3.2) + (A9.2), (A3.2) + (A10.1), (A3.2) + (A10.2), (A3.2) + (A13.2), (A3.2) + (A11.2), (A3.2) + (A12 .1), (A3.2) + (A12.2), (A3.2) + (A13.1), (A3.2) + (A13.2), (A3.2) + (A14.1 ), (A2.2) + (A14.2), (A3.2) + (A15.1), (A3.2) + (A15.2), (A3.2) + (A16.1), (A3.2) + (A16.2), (A3.2) + (A17.1), (A3.2) + (A17.2), (A3.2) + (A18.1), (A3 .2) + (A18.2),), (A3.2) + (A19.1), (A3.2) + (A19.2),
(A4.1) + (A4.2), (A4.1) + (A5.1), (A4.1) + (A5.2), (A4.1) + (A6.1), (A4 .1) + (A6.2), (A4.1) + (A7.1), (A4.1) + (A7.2), (A4.1) + (A8.1), (A4.1 ) + (A8.2), (A4.1) + (A9.1), (A4.1) + (A9.2), (A4.1) + (A10.1), (A4.1) + (A10.2), (A4.1) + (A11.1), (A4.1) + (A11.2), (A4.1) + (A12.1), (A4.1) + (A12 .2), (A4.1) + (A13.1), (A4.2) + (A13.2), (A4.1) + (A14.1), (A2.2) + (A14.2 ), (A4.1) + (A15.1), (A4.1) + (A15.2), (A4.1) + (A16.1), (A4.1) + (A16.2), (A4.1) + (A17.1), (A4.1) + (A17.2), (A4.1) + (A18.1), (A4.1) + (A18.2),), (A4.1) + (A19.1), (A4.1) + (A19.2),
(A4.2) + (A5.1), (A4.2) + (A5.2), (A4.2) + (A6.1), (A4.2) + (A6.2), (A4 .2) + (A7.1), (A4.2) + (A7.2), (A4.2) + (A8.1), (A4.2) + (A8.2), (A4.2 ) + (A9.1), (A4.2) + (A9.2), (A4.2) + (A10.1), (A4.2) + (A10.2), (A4.2) + (A11.1), (A4.2) + (A11.2), (A4.2) + (A12.1), (A4.2) + (A12.2), (A4.2) + (A13 .1), (A4.2) + (A13.2), (A4.2) + (A14.1), (A2.2) + (A14.2), (A4.1) + (A15.1 ), (A4.2) + (A15.2), (A4.2) + (A16.1), (A4.2) + (A16.2), (A4.2) + (A17.1), (A4.2) + (A17.2), (A4.2) + (A18.1), (A4.2) + (A18.2), (A4.2) + (A19.1), (A4 .2) + (A19.2),
(A5.1) + (A5.2), (A5.1) + (A6.1), (A5.1) + (A6.2), (A5.1) + (A7.1), (A5 .1) + (A7.2), (A5.1) + (A8.1), (A5.1) + (A8.2), (A5.1) + (A9.1), (A5.1 ) + (A9.2), (A5.1) + (A10.1), (A5.1) + (A10.2), (A5.1) + (A11.1), (A5.1) + (A11.2), (A5.1) + (A12.1), (A5.1) + (A12.2), (A5.1) + (A13.1), (A5.1) + (A13 .2), (A5.1) + (A14.1), (A2.2) + (A14.2), (A4.1) + (A15.1), (A5.1) + (A15.2 ), (A5.1) + (A16.1), (A5.1) + (A16.2), (A5.1) + (A17.1), (A5.1) + (A17.2), (A5.1) + (A18.1), (A5.1) + (A18.2), (A5.1) + (A19.1), (A5.1) + (A19.2),
(A5.2) + (A6.1), (A5.2) + (A6.2), (A5.2) + (A7.1), (A5.2) + (A7.2), (A5 .2) + (A8.1), (A5.2) + (A8.2), (A5.2) + (A9.1), (A5.2) + (A9.2), (A5.2) + (A10.1), (A5.2) + (A10.2), (A5.2) + (A11 .1), (A5.2) + (A11.2), (A5.2) + (A12.1), (A5.2) + (A12.2), (A5.2) + (A13.1 ), (A5.2) + (A13.2), (A5.2) + (A14.1), (A2.2) + (A14.2), (A4.1) + (A15.1), (A5.2) + (A15.2), (A5.2) + (A16.1), (A5.2) + (A16.2), (A5.2) + (A17.1), (A5 .2) + (A17.2), (A5.2) + (A18.1), (A5.2) + (A18.2), (A5.2) + (A19.1), (A5.2 ) + (A19.2), (A6.1) + (A6.2), (A6.1) + (A7.1), (A6.1) + (A7.2), (A6.1) + (A8.1), (A6.1) + (A8.2), (A6.1) + (A9.1), (A6.1) + (A9.2), (A6.1) + (A10 .1), (A6.1) + (A10.2), (A6.1) + (A11.1), (A6.1) + (A11.2), (A6.1) + (A12.1 ), (A6.1) + (A12.2), (A6.1) + (A13.1), (A6.1) + (A13.2), (A6.1) + (A14.1), (A2.2) + (A14.2), (A4.1) + (A15.1), (A6.1) + (A15.2), (A6.1) + (A16.1), (A6 .1) + (A16.2), (A6.1) + (A17.1), (A6.1) + (A17.2), (A6.1) + (A18.1), (A6.1 ) + (A18.2), (A6.1) + (A19.1), (A6.1) + (A19.2),
(A6.2) + (A7.1), (A6.2) + (A7.2), (A6.2) + (A8.1), (A6.2) + (A8.2), (A6 .2) + (A9.1), (A6.2) + (A9.2), (A6.2) + (A10.1), (A6.2) + (A10.2), (A6.2 ) + (A11.1), (A6.2) + (A11.2), (A6.2) + (A12.1), (A6.2) + (A12.2), (A6.2) + (A13.1), (A6.2) + (A13.2), (A6.2) + (A14.1), (A6.2) + (A14.2), (A6.1) + (A15 .1), (A6.2) + (A15.2), (A6.2) + (A16.1), (A6.2) + (A16.2), (A6.2) + (A17.1 ), (A6.2) + (A17.2), (A6.2) + (A18.1), (A6.2) + (A18.2), (A6.2) + (A19.1), (A6.2) + (A19.2),
(A7.1) + (A7.2), (A7.1) + (A8.1), (A7.1) + (A8.2), (A7.1) + (A9.1), (A7 .1) + (A9.2), (A7.1) + (A10.1), (A7.1) + (A10.2), (A7.1) + (A11.1), (A7.1 ) + (A11.2), (A7.1) + (A12.1), (A7.1) + (A12.2), (A7.1) + (A13.1), (A7.1) + (A13.2), (A7.1) + (A14.1), (A2.2) + (A14.2), (A4.1) + (A15.1), (A7.1) + (A15 .2), (A7.1) + (A16.1), (A7.1) + (A16.2), (A7.1) + (A17.1), (A7.1) + (A17.2 ), (A7.1) + (A18.1), (A7.1) + (A18.2), (A7.1) + (A19.1), (A7.1) + (A19.2),
(A7.2) + (A8.1), (A7.2) + (A8.2), (A7.2) + (A9.1), (A7.2) + (A9.2), (A7 .2) + (A10.1), (A7.2) + (A10.2), (A7.2) + (A11.1), (A7.2) + (A11.2), (A7.2 ) + (A12.1), (A7.2) + (A12.2), (A7.2) + (A13.1), (A7.2) + (A13.2), (A7.2) + (A14.1), (A2.2) + (A14.2), (A4.1) + (A15.1), (A7.2) + (A15.2), (A7.2) + (A16 .1), (A7.2) + (A16.2), (A7.2) + (A17.1), (A7.2) + (A17.2), (A7.2) + (A18.1 ), (A7.2) + (A18.2), (A7.2) + (A19.1), (A7.2) + (A19.2),
(A8.1) + (A8.2), (A8.1) + (A9.1), (A8.1) + (A9.2), (A8.1) + (A10.1), (A8 .1) + (A10.2), (A8.1) + (A11.1), (A8.1) + (A11.2), (A8.1) + (A12.1), (A8.1 ) + (A12.2), (A8.1) + (A13.1), (A8.1) + (A13.2), (A8.1) + (A14.1), (A2.2) + (A14.2), (A4.1) + (A15.1), (A8.1) + (A15.2), (A8.1) + (A16.1), (A8.1) + (A16 .2), (A8.1) + (A17.1), (A8.1) + (A17.2), (A8.1) + (A18.1), (A8.1) + (A18.2 ), (A8.1) + (A19.1), (A8.1) + (A19.2), (A8.2) + (A9.1), (A8.2) + (A9.2), (A8.2) + (A10.1), (A8.2) + (A10.2), (A8.2) + (A11.1), (A8.2) + (A11.2), (A8 .2) + (A12.1), (A8.2) + (A12.2), (A8.2) + (A13.1), (A8.2) + (A13.2), (A8.2 ) + (A14.1), (A2.2) + (A14.2), (A4.1) + (A15.1), (A8.2) + (A15.2), (A8.2) + (A16.1), (A8.2) + (A16.2), (A8.2) + (A17.1), (A8.2) + (A17.2), (A8.2) + (A18 .1), (A8.2) + (A18.2), (A8.2) + (A19.1), (A8.2) + (A19.2),
(A9.1) + (A9.2), (A9.1) + (A10.1), (A9.1) + (A10.2), (A9.1) + (A11.1), (A9 .1) + (A11.2), (A9.1) + (A12.1), (A9.1) + (A12.2), (A9.1) + (A13.1), (A9.1 ) + (A13.2), (A9.1) + (A14.1), (A2.2) + (A14.2), (A4.1) + (A15.1), (A9.1) + (A15.2), (A9.1) + (A16.1), (A9.1) + (A16.2), (A9.1) + (A17.1), (A9.1) + (A17 .2), (A9.1) + (A18.1), (A9.1) + (A18.2), (A9.1) + (A19.1), (A9.1) + (A19.2 )
(A9.2) + (A10.1), (A9.2) + (A10.2), (A9.2) + (A11.1), (A9.2) + (A11.2), (A9 .2) + (A12.1), (A9.2) + (A12.2), (A9.2) + (A13.1), (A9.2) + (A13.2), (A9.2 ) + (A14.1), (A2.2) + (A14.2), (A4.1) + (A15.1), (A9.2) + (A15.2), (A9.2) + (A16.1), (A9.2) + (A16.2), (A9.2) + (A17.1), (A9.2) + (A17.2), (A9.2) + (A18 .1), (A9.2) + (A18.2), (A9.2) + (A19.1), (A9.2) + (A19.2),
(A10.1) + (A10.2), (A10.1) + (A11.1), (A10.1) + (A11.2), (A10.1) + (A12.1), (A10 .1) + (A12.2), (A10.1) + (A13.1), (A10.1) + (A13.2), (A10.1) + (A14.1), (A10.1 ) + (A14.2), (A10.1) + (A15.1), (A10.1) + (A15.2), (A10.1) + (A16.1), (A10.1) + (A16.2), (A10.1) + (A17.1), (A10.1) + (A17.2), (A10.1) + (A18.1), (A10.1) + (A18 .2), (A10.1) + (A19.1), (A10.1) + (A19.2),
(A10.2) + (A11.1), (A10.2) + (A11.2), (A10.2) + (A12.1), (A10.2) + (A12.2), (A10 .2) + (A13.1), (A10.2) + (A13.2), (A10.2) + (A14.1), (A10.2) + (A14.2), (A10.2 ) + (A15.1), (A10.2) + (A15.2), (A10.2) + (A16.1), (A10.2) + (A16.2), (A10.2) + (A17.1), (A10.2) + (A17.2), (A10.2) + (A18.1), (A10.2) + (A18.2), (A10.2) + (A19 .1), (A10.2) + (A19.2), (A11.1) + (A11.2), (A11.1) + (A12.1), (A11.1) + (A12.2 ), (A11.1) + (A13.1), (A11.1) + (A13.2), (A11.1) + (A14.1), (A11.1) + (A14.2), (A11.1) + (A15.1), (A11.1) + (A15.2), (A11.1) + (A16.1), (A11.1) + (A16.2), (A11 .1) + (A17.1), (A11.1) + (A17.2), (A11.1) + (A18.1), (A11.1) + (A18.2), (A11.1 ) + (A19.1), (A11.1) + (A19.2),
(A11.2) + (A12.1), (A11.2) + (A12.2), (A11.2) + (A13.1), (A11.2) + (A13.2), (A11 .2) + (A14.1), (A11.2) + (A14.2), (A11.2) + (A15.1), (A11.2) + (A15.2), (A11.2 ) + (A16.1), (A11.2) + (A16.2), (A11.2) + (A17.1), (A11.2) + (A17.2), (A11.2) + (A18.1), (A11.2) + (A18.2), (A11.2) + (A19.1), (A11.2) + (A19.2),
(A12.1) + (A12.2), (A12.1) + (A13.1), (A12.1) + (A13.2), (A12.1) + (A14.1), (A12 .1) + (A14.2), (A12.1) + (A15.1), (A12.1) + (A15.2), (A12.1) + (A16.1), (A12.1 ) + (A16.2), (A12.1) + (A17.1), (A12.1) + (A17.2), (A12.1) + (A18.1), (A12.1) + (A18.2), (A12.1) + (A19.1), (A12.1) + (A19.2),
(A12.2) + (A13.1), (A12.2) + (A13.2), (A12.2) + (A14.1), (A12.2) + (A14.2), (A12 .2) + (A15.1), (A12.2) + (A15.2), (A12.2) + (A16.1), (A12.2) + (A16.2), (A12.2 ) + (A17.1), (A12.2) + (A17.2), (A12.2) + (A18.1), (A12.2) + (A18.2), (A12.2) + (A19.1), (A12.2) + (A19.2),
(A13.1) + (A13.2), (A13.1) + (A14.1), (A13.1) + (A14.2), (A13.1) + (A15.1), (A13 .1) + (A15.2), (A13.1) + (A16.1), (A13.1) + (A16.2), (A13.1) + (A17.1), (A13.1 ) + (A17.2), (A13.1) + (A18.1), (A13.1) + (A18.2), (A13.1) + (A19.1), (A13.1) + (A19.2), (A13.2) + (A14.1), (A13.2) + (A14.2), (A13.2) + (A15.1), (A13.2) + (A15 .2), (A13.2) + (A16.1), (A13.2) + (A16.2), (A13.2) + (A17.1), (A13.2) + (A17.2), (A13.2) + (A18.1), (A13 .2) + (A18.2), (A13.2) + (A19.1), (A13.2) + (A19.2),
(A14.1) + (A14.2), (A14.1) + (A15.1), (A14.1) + (A15.2), (A14.1) + (A16.1), (A14 .1) + (A16.2), (A14.1) + (A17.1), (A14.1) + (A17.2), (A14.1) + (A18.1), (A14.1 ) + (A18.2), (A14.1) + (A19.1), (A14.1) + (A19.2), (A14.2) + (A15.1), (A14.2) + (A15.2), (A14.2) + (A16.1), (A14.2) + (A16.2), (A14.2) + (A17.1), (A14.2) + (A17 .2), (A14.2) + (A18.1), (A14.2) + (A18.2), (A14.2) + (A19.1), (A14.2) + (A19.2 )
(A15.1) + (A15.2), (A15.1) + (A16.1), (A15.1) + (A16.2), (A15.1) + (A17.1), (A15 .1) + (A17.2), (A15.1) + (A18.1), (A15.1) + (A18.2), (A15.1) + (A19.1), (A15.1 ) + (A19.2), (A15.2) + (A16.1), (A15.2) + (A16.2), (A15.2) + (A17.1), (A15.2) + (A17.2), (A15.2) + (A18.1), (A15.2) + (A18.2), (A15.2) + (A19.1), (A15.2) + (A19 .2)
(A16.1) + (A16.2), (A16.1) + (A17.1), (A16.1) + (A17.2), (A16.1) + (A18.1), (A16 .1) + (A18.2), (A16.1) + (A19.1), (A16.1) + (A19.2),
(A16.2) + (A17.1), (A16.2) + (A17.2), (A16.2) + (A18.1), (A16.2) + (A18.2), (A16 .2) + (A19.1), (A16.2) + (A19.2),
(A17.1) + (A17.2), (A17.1) + (A18.1), (A17.1) + (A18.2), (A17.1) + (A19.1), (A17 .1) + (A19.2),
(A17.2) + (A18.1), (A17.2) + (A18.2), (A17.2) + (A19.1), (A17.2) + (A19.2),
(A18.1) + (A18.2), (A18.1) + (A19.1), (A18.1) + (A19.2),
(A18.2) + (A19.1), (A18.2) + (A19.2), (A19.1) + (A19.2).

In a preferred embodiment as component a), for example, various phenylsulfonylureas of the formula (II) and / or salts thereof are combined with one another, for example
Mesosulfuron-methyl + iodosulfuron-methyl,
Mesosulfuron-methyl + iodosulfuron-methyl-sodium,
Mesosulfuron-methyl + foramsulfuron,
Mesosulfuron-methyl + foramsulfuron sodium,
Mesosulfuron-methyl-sodium + iodosulfuron-methyl,
Mesosulfuron-methyl-sodium + iodosulfuron-methyl-sodium,
Mesosulfuron-methyl-sodium + foramsulfuron,
Mesosulfuron-methyl-sodium + foramsulfuron-sodium,
Foramsulfuron + iodosulfuron-methyl,
Foramsulfuron + iodosulfuron-methyl-sodium,
Foramsulfuron sodium + iodosulfuron-methyl,
Foramsulfuron sodium + Iodosulfuron methyl sodium.

The Sulfonamides a) and mixtures thereof, e.g. the aforementioned drug mixtures of phenylsulfonylureas of the formula (II) and / or salts thereof, can be combined with one or more safeners, in particular with the safeners mefenpyr-diethyl (S1-1), isoxadifen-ethyl (S1-9) and cloquintocetmexyl (S2-1).

All aforementioned combinations can also contain one or more agrochemically active substances (s), especially selected from the group (E1), (E1.1), (E1.2), (E1.3), (E1.4), (E1.5), (E2), (E2.1), (E2.2), (E2.3), (E2.4), (E2.5), (E2.6), (E2.7), (E2.8), (E2.9), (E3), (E3.1), (E3.2), (E3.3), (E4), (E4.1), (E4.2), (E5), (E5.1), (E5.2), (E6), (E6.1), (E6.2), (E6.3), (E6.4), (E6.5).

Provided in the oil suspension concentrates according to the invention as component a) mixtures of several sulfonamides are contained, e.g. the abovementioned mixtures of sulphonylureas of formula (II) and / or their salts, is at least one of Sulfonamides in suspended form, it can also all sulfonamides suspended.

The oil suspension concentrates according to the invention can by known methods, e.g. by mixing the components getting produced. Thus, e.g. a premix are made, wherein the sulfosuccinate d) is dissolved in the organic solvent c) and this solution, if appropriate, further auxiliaries and additives f) are added. Then, optionally used soluble agrochemical agents b) and e) dissolved in the premix. After completion of the resolution process becomes solid sulfonamide a) and optionally used insoluble active ingredients b) and e) suspended in the mixture. The coarse suspension is optionally after a pre-grinding, subjected to a fine grinding.

In another embodiment becomes solid sulfonamide a), as well as any insoluble components used b), e) and f), in a mixture of the organic solvent c) and the sulfosuccinate d) and subjected to grinding. Optionally used soluble Active ingredients b) and e) and auxiliaries and additives from f), none Require grinding or for The grinding process is not necessary, after grinding added.

to Preparation of the mixtures can common Mixing apparatus are used, which are optionally tempered. For pre-grinding can e.g. High-pressure homogenizers or according to the rotor-stator principle working mills such as Ultraturax homogenizers, e.g. the Fa. IKA, or Toothed colloid mills, e.g. the Fa. Puck. For the fine grinding can e.g. discontinuous bead mills, e.g. from Drais or continuous bead mills, e.g. Fa. Bachofen be used. Depending on the properties of the components used, as well as procedural and safety requirements and economical reasons, can adapt the manufacturing process and optionally to a Pre-grinding or dispensing with a fine grinding.

The Components used for the preparation of components a) to f) may be water contained as a minor component, which is in the oil suspension concentrates according to the invention finds. The oil suspension concentrates according to the invention can therefore contain small amounts of water, generally from 0 to 5% by weight. Preferably, the oil suspension concentrates according to the invention subjected to no further drying process.

to Application can the oil suspension concentrates according to the invention if appropriate in usual Way, e.g. to suspensions, emulsions, suspoemulsions or solutions, preferably suspensions, e.g. by means of water. It may be advantageous to spray mixtures obtained further agrochemical active ingredients (e.g., tank mix partners in the form of appropriate formulations) and / or usual for use Auxiliaries and additives, e.g. self-emulsifying oils such as vegetable oils or paraffin oils and / or fertilizers admit. The subject of the present invention is therefore also such herbicidal compositions, based on the oil suspension concentrates according to the invention.

The herbicides according to the invention Means have excellent herbicidal activity against Broad spectrum of economically important monocotyledonous and dicotyledonous harmful plants on. Also difficult to combat perennial weeds, from rhizomes, rhizomes or other permanent organs are well detected. there can the means e.g. in pre-sowing, pre-emergence or post-emergence procedures be applied. In particular, some representatives called the monocotyledonous and dicotyledonous weed flora, by the herbicidal invention Means can be controlled without that through the mention a restriction to be done in certain ways.

On the side of the monocotyledonous weed species are e.g. Apera spica venti, Avena spp., Alopecurus spp., Brachiaria spp., Digitaria spp., Lolium spp., Echinochloa spp., Panicum spp., Phalaris spp., Poa spp., Setaria spp. and Bromus spp. like Bromus catharticus, Bromus secalinus, Bromus erectus, Bromus tectorum and Bromus japonicus and cyperus species from the annuell group and on the side of the perennial species Agropyron, Cynodon, Imperata, as well as sorghum and perennial Cyperus species well detected.

at dicotyledonous weed species extends the spectrum of action on species such as. Abutilon spp., Amaranthus spp., Chenopodium spp., Chrysanthemum spp., Galium spp. such as Galium aparine, Ipomoea spp., Kochia spp., Lamium spp., Matricaria spp., Pharitis spp., Polygonum spp., Sida spp., Sinapis spp., Solanum spp., Stellaria spp., Veronica spp. and Viola spp., Xanthium spp., on the annall side as well as Convolvulus, Cirsium, Rumex and Artemisia at perennial weeds.

Under the specific culture conditions in rice occurring harmful plants such as. Echinochloa, Sagittaria, Alisma, Eleocharis, Scirpus and Cyperus are also excellent in the compositions of the invention fought.

Become the herbicides according to the invention Means applied before germination on the earth's surface, so will either completely prevents the emergence of the weed seedlings or grow the weeds to the cotyledon stage, but then put their growth one and finally die completely after three to four weeks.

at Application of the herbicides according to the invention Means on the greens Plant parts postemergence also occurs very quickly after the treatment a drastic halt in growth and the weed plants stay in the growth stage at the time of application stand or die completely after a certain time, so that on this Way one for the crops harmful Weed competition very early and sustainably eliminated.

The herbicidal compositions according to the invention are distinguished by a rapidly onset and long-lasting herbicidal action. The rainfastness of the active ingredients in the combination according to the invention It is usually cheap. A particular advantage is the fact that the effective and used in herbicidal compositions doses of herbicidal compounds can be set so low that their soil effect is optimally low. Thus, their use is not only possible in sensitive cultures, but groundwater contamination is virtually avoided. The combination of active substances according to the invention enables a considerable reduction in the required application rate of the active ingredients.

The said properties and benefits are in the practical weed control of Use to eliminate agricultural crops from unwanted Competing plants and thus the yields qualitatively and quantitatively secure and / or increase. The technical standard is characterized by these new agents in terms of the properties described clearly exceeded.

Although the herbicides according to the invention Means have excellent herbicidal activity against mono- and dicotyledonous weeds, are crops of economically important crops, e.g. dicotyledonous Cultures such as soy, cotton, rapeseed, sugar beets, or graminaceous crops such as wheat, barley, rye, oats, millet, rice or corn, only marginally or not damaged at all. The present compounds are very suitable for these reasons good for selective control unwanted Plant growth in agricultural crops or ornamental plantings.

Furthermore have the herbicides according to the invention Means excellent growth regulatory properties in crops on. They regulate the plant's metabolism one and can thus for the targeted influencing of phytonutrients and for harvest relief, e.g. by triggering desiccation and stunted growth be used. Furthermore, they are also suitable for general Control and inhibition of unwanted vegetative growth without killing the plants. A Inhibition of vegetative growth plays in many mono- and dicots Cultures a big one Role, since the storage can be reduced or completely prevented.

by virtue of their herbicidal and plant growth regulatory properties, the herbicides according to the invention Means also to fight of harmful plants in crops of known or yet to be developed genetically modified Plants are used. The transgenic plants are distinguished usually by special advantageous properties, for example through resistance certain pesticides, especially certain herbicides, resistance across from Plant diseases or pathogens of plant diseases such as certain Insects or microorganisms such as fungi, bacteria or viruses. Other special properties relate to z. B. the crop in terms Quantity, quality, shelf life, Composition and special ingredients. So are transgenic Plants with elevated starch content or changed quality the strength or those with a different fatty acid composition the crop is known.

Prefers the use of the agents according to the invention is economical important transgenic crops of useful and ornamental plants, eg. B. of Gramineae crops like wheat, barley, rye, oats, millet, rice and corn or even Crops of sugar beet, Cotton, soya, rapeseed, potato, tomato, pea and other vegetables. Preferably the agents according to the invention are used as herbicides in crops, which across from the phytotoxic effects of herbicides are resistant or genetically have been made resistant.

at the application of the herbicidal invention Agents in transgenic cultures occur alongside those in other cultures to observable effects Harmful plants often have effects that apply to the application in the respective transgenic culture are specific, for example, a modified or specially extended weed spectrum that can be controlled can, changed Application rates for the application can be used, preferably good combinability with the herbicides, opposite which the transgenic culture is resistant, as well as influencing Growth and yield of transgenic crops.

object The present invention also provides a method for fight unwanted Plant growth, preferably in crops such as cereals (e.g. Wheat, barley, rye, oats, rice, corn, millet), sugar beet, cane, Rapeseed, cotton and soybeans, especially preferred in monocotyledonous crops such as cereals, e.g. Wheat, barley, rye, oats, crosses thereof like triticale, rice, corn and millet, taking one or more herbicides according to the invention Means to harmful plants, parts of plants, plant seeds or the area on which the plants grow, e.g. applied the acreage.

The plant cultures can also be genetically modified or obtained by mutation selection and are preferably tolerant to acetolactate synthase (ALS) inhibitors.

The oil suspension concentrate The present invention has excellent chemical stability during the Production and storage and is particularly suitable for combinations of active substances with different physicochemical properties, z. B. one in organic solvents slightly soluble herbicidal phenylsulfonamide with a soluble safener and optionally further soluble agrochemical active ingredients. Furthermore has the oil suspension concentrate excellent physical stability, good applicability and ease of use, as well as high biological effectiveness and selectivity.

If not otherwise described were those in the following examples said oil suspension concentrates prepared as follows: A premix was prepared in which the sulfosuccinate d) in the solvent c) solved and this solution, the other auxiliaries and additives f) were added. Then it became the safener b) dissolved in the premix. After completion of the solution process solid sulfonamide a) was suspended in the mixture. The rough Suspension was, after a pre-grinding, a fine grinding subjected.

The abbreviations used in the following examples have the following meaning:
Iodosulfuron = 3- (4-methoxy-6-methyl-1,3,5-triazin-2-yl) -1- (2-methoxycarbonyl-5-iodo-phenylsulfonyl) -urea sodium salt
Thifensulfuron = 3- (4-methoxy-6-methyl-1,3,5-triazin-2-yl) -1- (2-methoxycarbonylthiophenesulfonyl) -urea sodium salt
Mefenpyr = ethyl 1- (2,4-dichlorophenyl) -5- (ethoxycarbonyl) -5-methyl-2-pyrazoline-3-carboxylate
Bentone ^® 34 = modified layered silicate, Elementis
Edenor ^® MESU = Rapsölmethylester, Cognis
Emulsogen ^® EL-400 = polyethoxylated castor oil with 40 ethylene oxide units, Clariant
Genapol ^® PF10 = polyethylene oxide-polypropylene oxide block copolymer with 10% ethylene oxide units, Clariant
Genapol ^® V4739 = polyethoxylated isotridecanol having 6 ethylene oxide units, methoxy-capped, Clariant
Jeffsol ^® PC = propylene carbonate, Huntsman
Solvesso ^® 200 = aromatic mineral oil (boiling range 219-281 ° C), Exxon
Thixatrol ^® ST = Thixothropiermittel based on a Riziniusölderivates
^Triton® GR-7M E = di (2-ethylhexyl) sulfosuccinate sodium salt in aromatic solvent, Union Carbide
8W40 ° C = 8 week storage test at 40 ° C

Example 1:

manufacturing an oil suspension concentrate

The Concentration of iodosulfuron was determined by HPLC before and after Preparation of the oil suspension concentrate certainly.

Table 1: Chemical stability of component a) during production (all data in grams)

Example 2:

manufacturing and storage of an oil suspension concentrate

The Concentration of iodosulfuron was determined by HPLC before and after Preparation of the oil suspension concentrate as well as after 8 weeks Storage at 40 ° C certainly.

Table 2: Chemical stability of component a), during production and storage (all data in% by weight)

Example 3:

Preparation of an oil suspension concentrate

The Concentration of thifensulfuron was determined by HPLC before and after the preparation of the oil suspension concentrate certainly.

The inventive example 3.1 showed a significantly higher chemical stability as the comparative example 3.2

Claims (14)

An oil suspension concentrate comprising a) one or more herbicidal active substances from the group of sulfonamides, in suspended form, b) one or more safeners, c) one or more organic solvents, and d) one or more sulfosuccinates. Oil suspension concentrate according to claim 1, which are contained as component a), one or more herbicides Active substances from the group of phenylsulfonamides, preferably the Phenylsulfonylaminocarbonyltriazolinones and phenylsulfonylureas, or the heteroarylsulfonamides, preferably the heteroarylulfonylaminocarbonyltriazolinones and heteroarylsulfonylureas. Oil suspension concentrate according to claim 1 or 2, which are contained as component b), one or more Safeners from the group Dichlorphenylpyrazolin-3-carboxylic acid and their esters, 5,5-diphenyl-2-isoxazoline-3-carboxylic acid their Ester and 8-quinolinoxyacetic acid and their esters. Oil suspension concentrate according to one or more of the claims 1 to 3, which are contained as component c), one or more solvent from the group of unsubstituted or substituted hydrocarbons, aprotic polar solvents and fatty acid esters. Oil suspension concentrate according to one or more of the claims 1 to 4, which contain as component d), one or more Sulfosuccinates from the group of mono- and diesters of sulfosuccinic acid. Oil suspension concentrate according to one or more of the claims 1 to 5, in addition containing e) one or more of a) and b) different agrochemical Active substances and / or f) usual Auxiliaries and additives. Process for the preparation of an oil suspension concentrate according to or more of claims 1 to 6, wherein the components are mixed and optionally ground become. Method of control of harmful plants, wherein an effective amount of an oil suspension concentrate according to one or more of the claims 1 to 6 on the harmful plants, parts of the plants, plant seeds, the area is applied to the plants grow. Use of an oil suspension concentrate according to one or more of the claims 1 to 6, to combat of harmful plants. Use of an oil suspension concentrate according to a or more of the claims 1 to 6, for the preparation of a herbicidal composition. Use according to claim 10, wherein the herbicidal agent is a suspension, emulsion, suspoemulsion or a solution is. A herbicidal composition containing an oil suspension concentrate according to one or more of the claims 1 to 6. Method for controlling harmful plants, in which an effective amount of a herbicidal composition according to claim 12 on the harmful plants, Parts of the plants, plant seeds, the area on the plants grow is applied. Use of a herbicidal composition according to claim 12, to combat of harmful plants.